WO2017169751A1 - Method for producing enzyme derived from psychrophilic or mesophilic microorganism - Google Patents

Method for producing enzyme derived from psychrophilic or mesophilic microorganism Download PDF

Info

Publication number
WO2017169751A1
WO2017169751A1 PCT/JP2017/010265 JP2017010265W WO2017169751A1 WO 2017169751 A1 WO2017169751 A1 WO 2017169751A1 JP 2017010265 W JP2017010265 W JP 2017010265W WO 2017169751 A1 WO2017169751 A1 WO 2017169751A1
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
culture
temperature
bacterium
derived
Prior art date
Application number
PCT/JP2017/010265
Other languages
French (fr)
Japanese (ja)
Inventor
正裕 高橋
秀昭 村上
Original Assignee
イムラ・ジャパン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イムラ・ジャパン株式会社 filed Critical イムラ・ジャパン株式会社
Priority to JP2018508977A priority Critical patent/JPWO2017169751A1/en
Publication of WO2017169751A1 publication Critical patent/WO2017169751A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Definitions

  • the present invention relates to a method for producing enzymes derived from thermophilic bacteria and mesophilic bacteria.
  • Enzymes are widely used in various fields such as foods, pharmaceuticals, cosmetics and functional materials because they can synthesize and decompose organic substances with low energy and do not generate by-products such as chemical synthesis.
  • a method for producing an enzyme in addition to a method for extracting an enzyme in various organisms, a method for culturing a transformant in which a DNA encoding a target enzyme is introduced into a host microorganism and expressing the enzyme is known.
  • Escherichia coli, yeast and the like have been widely used conventionally.
  • an enzyme derived from the host microorganism is also expressed and activated at the same time. Therefore, the expression of the target enzyme is controlled to make the enzyme efficient. Development of a method for manufacturing well is desired.
  • Patent Document 1 As a method for producing an enzyme using a transformant, for example, in Japanese Patent Application Laid-Open No. 2011-160778 (Patent Document 1), a mycobacteria is transformed using a gene encoding a thermostable enzyme. A production method including a step of obtaining a transformant and a step of obtaining an immobilized thermostable enzyme by heat-treating the transformant is described. However, the method described in Patent Document 1 is a method for producing a thermostable enzyme derived from a hyperthermophilic bacterium or a thermophilic bacterium, and the obtained enzyme has to be reacted at a high temperature.
  • the present invention has been made in view of the above-described problems of the prior art, and separates the growth stage of transformants into which DNAs encoding enzymes derived from psychrophilic and mesophilic bacteria are introduced and the expression stage of the enzyme. It is an object of the present invention to provide a method for producing a thermophilic bacterium and an enzyme derived from a mesophilic bacterium.
  • thermophilic bacteria having an optimum growth temperature are high (50 ° C. or higher) and that the optimum growth temperature is low (50 ° C. or lower and the thermophilic).
  • the transformant thus obtained is first cultured at a high temperature (50 ° C. or higher), and then cultured at a low temperature (50 ° C. or lower and 10 ° C. or higher).
  • the expression stage of the enzyme derived from the psychrophilic bacterium and the mesophilic bacterium are found out, and the present invention has been completed.
  • the method for producing the psychrophilic and mesophilic bacterium-derived enzymes of the present invention comprises: A group consisting of a thermophilic bacterium having an optimal growth temperature of 50 ° C. or higher, a thermophilic bacterium having an optimal growth temperature of 50 ° C. or lower and a temperature lower by 10 ° C. or more than the optimal growth temperature of the thermophilic bacterium
  • a third step of expressing the enzyme by changing the culture temperature to 50 ° C. or lower and a temperature lower by 10 ° C. or higher than the culture temperature of the second step; Is included.
  • the culture temperature in the second step is preferably 55 to 87 ° C.
  • the culture temperature in the third step is 25 to 45 ° C. It is preferable.
  • the culturing temperature of the second step is changed to the third step. It is preferable to change the culture temperature.
  • the enzyme reaction method of the present invention is a method in which the enzyme obtained by the above-described method for producing a thermophilic bacterium and a mesophilic bacterium-derived enzyme of the present invention is brought into contact with a substrate of the enzyme and reacted.
  • the “optimum growth temperature” refers to the temperature at which a microorganism grows most rapidly, and the temperature at which the specific growth rate obtained by culturing the microorganism for a certain period of time at each temperature is the highest. Optimal growth temperature can be achieved.
  • a method for producing a psychrophilic bacterium and a mesophilic bacterium-derived enzyme capable of separating a growth stage of a transformant introduced with DNA encoding an enzyme derived from a psychrophilic bacterium and a mesophilic bacterium and an expression stage of the enzyme can be provided. Therefore, for example, by producing a transformant so that the enzyme derived from the psychrotrophic and mesophilic bacterium is expressed in the secretory system, after growing at a high temperature, the medium is changed, and then the culture temperature is changed to a low temperature.
  • thermophilic bacterium and a mesophilic bacterium can be selectively obtained in a medium, the enzyme can be easily recovered and purified.
  • the activity of the enzyme derived from the thermophilic bacterium that is the host microorganism is suppressed near the optimum temperature of the enzyme derived from the thermophilic bacterium and mesophilic bacterium obtained, the culture solution containing the transformant can be used for the enzyme reaction as it is. It becomes possible.
  • FIG. 2 is a growth curve obtained in Examples 1 and 2 and Comparative Example 1. It is the photograph which image
  • FIG. FIG. 3 is a photograph of the appearance when ⁇ -galactosidase activity was evaluated for culture broths cultured for 3 hours from the start of culture in the third step of Examples 1 and 2 and Comparative Example 1.
  • FIG. FIG. 3 is a photograph of the appearance when ⁇ -galactosidase activity evaluation was performed on culture broths cultured for 24 hours from the start of culture in the third step of Examples 1 and 2 and Comparative Example 1.
  • FIG. 4 is a growth curve obtained in Examples 3 to 4 and Comparative Example 2. It is the photograph which image
  • FIG. FIG. 4 is a photograph of the appearance when ⁇ -galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. .
  • FIG. 4 is a photograph of the appearance when ⁇ -galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 6 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. . It is the photograph which image
  • FIG. FIG. 3 is a photograph of the appearance when ⁇ -galactosidase activity evaluation (incubation time: 3 hours) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. .
  • the method for producing the thermophilic bacterium and the mesophilic bacterium-derived enzyme of the present invention comprises: A group consisting of a thermophilic bacterium having an optimal growth temperature of 50 ° C. or higher, a thermophilic bacterium having an optimal growth temperature of 50 ° C. or lower and a temperature lower by 10 ° C. or more than the optimal growth temperature of the thermophilic bacterium
  • a third step of expressing the enzyme by changing the culture temperature to 50 ° C. or lower and a temperature lower by 10 ° C. or higher than the culture temperature of the second step; including.
  • thermophilic bacterium is a microorganism having an optimal growth temperature of 50 ° C. or higher.
  • thermophilic bacteria include thermophilic eubacteria, hyperthermophilic eubacteria, thermophilic archaea and hyperthermophilic archaea. From the viewpoint of easy expression, eubacteria are used as host microorganisms. Since it is preferable to express an eubacteria-derived enzyme as an enzyme derived from the following thermophilic bacteria and mesophilic bacteria, it is more preferably a thermophilic eubacteria or a hyperthermophilic eubacteria.
  • thermophilic means that the optimum growth temperature of the microorganism is 50 ° C. or more and less than 80 ° C.
  • super thermophilicity means that the optimum growth temperature of the microorganism is 80 ° C. or more. Point to.
  • thermophilic eubacteria and the hyperthermophilic eubacteria are available from public institutions, have a track record of producing transformants, or tend to be relatively easy to produce transformants.
  • Geobacillus examples include Geobacillus thermoglucosidasis (optimum growth temperature: 55 ° C.), Geobacillus kaustophilus (optimum growth temperature: 55 ° C.), Geobacillus s. stearothermophilus, optimal growth temperature: 55 ° C., Geobacillus subterraneus (optimal growth temperature: 55 ° C.), Geobacillus uzenensis, optimal growth temperature: 55 ° C. Geobacillus thermocate ulatas, optimal growth temperature: 60 ° C.), Geobacillus thermodenitificans, optimal growth temperature: 60 ° C., Geobacillus thermoreovorans, optimal growth temperature: 60 ° C. Can be mentioned.
  • Bacillus examples include Bacillus thermanticus (Bacillis thermalarticus, optimal growth temperature: 55 ° C.).
  • Thermus genus examples include Thermos thermophilus (Thermus thermophilus, optimal growth temperature: 75 ° C.), Thermus aquaticus (Thermus aquaticus, optimal growth temperature: 70 ° C.).
  • Thermotoga maritima Thermotoga maritima (optimum growth temperature: 80 ° C.), Thermotoga naphtophyla (Optimum growth temperature: 80 ° C.), Thermotoga neapolitana (therma tomato temperature) : Thermotoga petrophila (Thermotoga petrophila, optimal growth temperature: 80 ° C), and the Pseudothermotoga retingae (Pseudothermotoga lettingae, optimal growth temperature: 65 ° C).
  • Thermotoga maritima Thermotoga maritima (optimum growth temperature: 80 ° C.)
  • Thermotoga naphtophyla Optimum growth temperature: 80 ° C.
  • Thermotoga neapolitana thermoa tomato temperature
  • Thermodesulfobacterium examples include Thermodesulfobacterium commune (optimum growth temperature: 70 ° C.).
  • Aquifex aeolicus As the genus Aquifex, Aquifex aeolicus (optimus aeolicus) is optimal. Growth temperature: 85 ° C.) and Aquifex pyrophilus (optimum growth temperature: 85 ° C.).
  • thermophilic archaea and the hyperthermophilic archaea are available from public institutions, have a track record of producing transformants, or tend to be relatively easy to produce transformants.
  • Aeropyram genus, Alcaeoglobus genus, Methanocordococcus genus, Methanothermobacter genus, Pyrococcus genus, and Sulfolobas genus are preferable.
  • Examples of the genus Aeropyrum include Aeropyrum pernicus (optimum growth temperature: 90 ° C.), and examples of the genus Alcaeoglobus include Archaeoglobus fulgidus (optimum growth temperature: 85).
  • the Methanocordococcus genus includes Methanocardococcus jannaschii (optimum growth temperature: 80 ° C.), and the Methanothermobacter genus includes the Methanothermobacter thermoautotro. And Ficus (Methanotherbacter thermotrophicus, optimal growth temperature: 65 ° C.).
  • Examples of the Pyrococcus genus include Pyrococcus furiosus (Pyrococcus furiosus, optimal growth temperature: 97 ° C.), Pyrococcus horikoshi (Pyrococcus horikoshii, optimal growth temperature: 95 ° C.), Pyrococcus abyssi (Pyrococcus, optimal growth).
  • Examples of the sulfolobus include Sulfolobus solfataricus (Sulfobus solfataricus, optimum growth temperature: 70 ° C.), Sulfolobus tokodaii, optimum growth temperature: 75 ° C. .
  • the optimum growth temperature of the thermophilic bacterium according to the present invention needs to be 50 ° C. or higher. If the optimal growth temperature of the thermophile is less than the lower limit, it becomes difficult to separate the growth stage of the transformant and the expression stage of the enzyme. Moreover, as the optimal growth temperature of the thermophilic bacterium, the growth stage of the transformant and the expression stage of the enzyme can be further distinguished, and the culture for growing the transformant is easier. In view of the above, it is preferably 55 to 87 ° C, more preferably 55 to 65 ° C.
  • thermophilic and mesophilic bacteria are microorganisms having an optimum growth temperature of 50 ° C. or lower.
  • the thermophilic bacterium refers to a microorganism having an optimal growth temperature of less than 30 ° C.
  • the mesophilic bacterium refers to a microorganism having an optimal growth temperature of 30 to 50 ° C.
  • examples of such a thermophilic bacterium and mesophilic bacterium include eubacteria, archaea, and eukaryotes.
  • an eubacteria is used as a host microorganism, and the following psychrophilic and mesophilic bacterium-derived enzymes are used: Since it is preferable to express an eubacteria-derived enzyme, eubacteria are more preferable.
  • thermophilic bacterium and the mesophilic bacterium are not particularly limited.
  • Bacterial glutamium Corynebacterium glutamicum, optimal growth temperature: 28 ° C
  • Lactococcus lactis Lactococcus lactis, optimal growth temperature: 30 ° C
  • Clostridium acetobutylicum (Crostridium acetobutylicum, optimal temperature 37 ° C)
  • Pseudomonas mevaloni Pseudomonas mevalonii, optimal growth temperature: 30 ° C.
  • thermophilic bacterium and the mesophilic bacterium are not particularly limited, and examples thereof include Methanosarcina mazei (optimum growth temperature: 37 ° C.). Further, eukaryotes as the above-mentioned thermophilic bacteria and mesophilic bacteria are not particularly limited, and examples thereof include Saccharomyces cerevisiae (optimum growth temperature: 25 ° C.).
  • thermophilic bacterium and mesophilic bacterium Escherichia coli, Bacillus subtilis, Clostridium acetobutylicum, and Saccharomyces cerevisiae are preferable, and Escherichia coli is particularly preferable from the viewpoint that there is a tendency to use many enzymes derived from the microorganism.
  • the optimum growth temperature of the thermophilic bacterium and mesophilic bacterium according to the present invention is 50 ° C. or lower, and from the growth temperature of thermophilic bacterium used as a host cell into which DNA encoding the enzyme derived from the psychrophilic bacterium and mesophilic bacterium is introduced. Also, it must be 10 ° C. or more lower. If the optimum growth temperature of the thermophilic bacterium and the mesophilic bacterium exceeds the upper limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic bacteria and the mesophilic bacterium-derived enzyme.
  • the growth stage of the transformant and the expression stage of the enzyme can be further distinguished, and the expression level of the enzyme can be increased.
  • it is preferably 25 to 45 ° C, more preferably 25 to 40 ° C.
  • thermophilic bacteria cold bacteria and mesophilic bacteria
  • BGSC Bactet al.
  • ATCC American Type Culture Collection
  • DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen (German Collection of Microorganisms and Cell Cultures)
  • NPMD National Institute of Technology and Evaluation, Patent Biological Depositary Center
  • private sales companies e.g., NPMD (National Institute of Technology and Evaluation, Patent Biological Depositary Center) and private sales companies.
  • the "Pyrogen and mesophilic bacterium-derived enzyme” is an enzyme derived from at least one microorganism selected from the group consisting of the psychrophilic bacterium and the mesophilic bacterium.
  • examples of such enzymes include, but are not limited to, for example, sugar metabolism enzymes derived from E.
  • glycolytic enzymes non-mevalonate pathway enzymes, butanol fermentation enzymes, fatty acid synthetases; glycolytic enzymes derived from Bacillus subtilis, Non-mevalonate pathway enzyme, butanol fermentation enzyme; Butanol fermentation enzyme derived from Corynebacterium glutamine, Shikimate pathway enzyme; Butanol fermentation enzyme derived from Lactococcus lactis; Acetone-butanol-ethanol fermentation enzyme derived from Clostridium acetobutylicum; Pseudomonas -Mevalonate pathway enzyme derived from mevaloni; mevalonate pathway enzyme derived from methanosarkina mazei; glycolytic enzyme derived from Saccharomyces cerevisiae, ethanol fermentation enzyme, and mevalonate pathway enzyme.
  • ⁇ -galactosidase lacZ
  • the glycolytic enzymes derived from the Escherichia coli, Bacillus subtilis, or Saccharomyces cerevisiae include hexokinase, glucose-6-phosphate isomerase, phosphofructokinase-1, fructose 1,6-bisphosphate aldolase, triose phosphate.
  • Preferred are isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, phosphopyruvate hydratase, and pyruvate kinase.
  • Non-mevalonate pathway enzymes derived from the E. coli or Bacillus subtilis include DOXP synthase, DOXP reductoisomerase, 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, 4-diphosphoditidyl-2-C-methyl-D. -Erythritol kinase, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase, HMB-PP synthase, HMB-PP reductase, isopentenyl diphosphate isomerase are preferred.
  • ketol acid reductoisomerase and dihydroxy acid dehydratase are preferable.
  • butanol-fermenting enzyme derived from Bacillus subtilis acetolactate synthase is preferable, butanol-fermenting enzyme derived from Corynebacterium glutamicum.
  • ketol acid reduct isomerase dihydroxy acid dehydratase, Alcohol dehydrogenase is preferred, and the butanol fermentation enzyme derived from Lactococcus lactis is preferably keto acid decarboxylase.
  • fatty acid synthase derived from E. coli, acetyl-CoA carboxylase, ACP-acetyltransferase, ACP-malonyltransferase, ⁇ -ketoacyl-ACP synthase, ⁇ -ketoacyl ACP reductase, 3-hydroxyacyl ACP dehydrase, and enoyl ACP reductase are preferable. .
  • shikimate pathway enzyme derived from Corynebacterium glutamicum
  • shikimate pathway enzyme examples include 7-phospho-2-dehydro-3-deoxyarabinoheptonic acid aldolase, 3-dehydroquinic acid synthase, 3-dehydroquinic acid dehydratase, shikimate dehydrogenase, shikimate Kinase, 3-phosphoshikimate 1-carboxyvinyltransferase, chorismate synthase, chorismate mutase are preferred.
  • Examples of the acetone-butanol-ethanol fermentation enzyme derived from Clostridium acetobutylicum include pyruvate synthase, thiolase, 3-hydroxybutyryl-CoA dehydrogenase, crotonyl CoA hydratase, butyryl CoA dehydrogenase, acetaldehyde dehydrogenase, ethanol dehydrogenase, butyraldehyde dehydrogenase, butanol Dehydrogenase and acetoacetate decarboxylase are preferred.
  • HMG-CoA reductase As the mevalonate pathway enzyme derived from Pseudomonas mevaloni, HMG-CoA reductase is preferable, and as the mevalonate pathway enzyme derived from Methanosarcina mazei or Saccharomyces cerevisiae, acetyl CoA synthase, acetyl CoA-acetyltransferase, HMG-CoA synthase HMG-CoA reductase, mevalonate kinase, 5-phosphomevalonate kinase, diphosphomevalonate decarboxylase, isopentenyl diphosphate ⁇ -isomerase are preferred. As the ethanol fermentation enzyme derived from Saccharomyces cerevisiae, pyruvate decarboxylase and alcohol dehydrogenase are preferable.
  • thermophilic bacteria and mesophilic bacteria As the enzymes derived from thermophilic bacteria and mesophilic bacteria according to the present invention, one of the above may be expressed alone, or two or more of them may be expressed in combination. Among these, as the enzyme derived from the psychrotrophic bacterium and mesophilic bacterium, ⁇ -galactosidase, pyruvate decarboxylase, and alcohol dehydrogenase are preferable, and ⁇ -galactosidase is particularly preferable from the viewpoint of tending to be used.
  • DNA sequence information encoding the above-mentioned enzymes derived from thermophilic and mesophilic bacteria should be obtained from publicly available databases such as DDBJ (DNA Data Bank of Japan), GenBank, EMBL (European Molecular Biology Laboratory). Can do.
  • the first step according to the production method of the present invention is a step of obtaining a transformant by introducing DNA encoding the enzyme derived from the thermophilic bacterium and the mesophilic bacterium into the thermophilic bacterium.
  • the method for obtaining the transformant is not particularly limited, and a known method or conditions obtained by appropriately modifying the known method can be appropriately employed.
  • DNA encoding the target thermophilic bacteria and mesophilic bacteria-derived enzyme is isolated from the target thermophilic bacteria and / or mesophilic bacteria by conventional methods, and an expression vector capable of self-replication containing the isolated DNA is prepared.
  • the target transformant can be obtained by introduction into a thermophilic bacterium.
  • the target transformant can also be obtained by introducing an expression vector containing the isolated DNA into the hyperthermic bacterium and integrating the DNA into the genome of the hyperthermic bacterium by conjugation transfer or the like.
  • Examples of the DNA isolation method include PCR using primers prepared based on the base sequences of the target psychrotrophic and mesophilic bacterium-derived enzymes and the genomic DNA of the target psychrophilic and / or mesophilic bacterium as a template.
  • To isolate the desired genomic DNA by ligating the amplified DNA fragment with an appropriate vector; extracting genomic DNA or mRNA from the target psychrotrophic and / or mesophilic bacterium and synthesizing based on this
  • the prepared cDNA is ligated with an appropriate vector to prepare a DNA library or cDNA library, and desired from the library by hybridization using a probe prepared based on the base sequences of the target thermophilic and mesophilic bacteria.
  • the expression vector is a vector containing a protein encoded by the polynucleotide sequence in an expressible state, and is preferably replicable in the thermophilic bacterium.
  • the expression vector is constructed based on a plasmid, phage, or cosmid. be able to.
  • the plasmid serving as the parent of the expression vector can be appropriately selected according to the type of thermophile into which the expression vector is introduced and the method of introduction.
  • pNW33N GenBank ID: AY237122.1
  • pUB110 GeneBank ID: M19465.1
  • pSTK1 GeneBank ID: D29989.1
  • pTB19 GeneBank ID: M63891.1
  • examples thereof include plasmids such as the pGAM46 plasmid described in 7376-7383 and derivatives thereof.
  • a polynucleotide sequence for controlling the expression in order to express the enzyme by actually introducing the enzyme into the thermophilic bacterium Or a genetic marker for selecting a transformant in addition to DNA encoding the enzyme derived from the thermophilic bacterium and the mesophilic bacterium, a polynucleotide sequence for controlling the expression in order to express the enzyme by actually introducing the enzyme into the thermophilic bacterium Or a genetic marker for selecting a transformant. Further, it preferably further comprises a purification tag sequence for purifying the enzyme derived from the thermophilic bacterium and the mesophilic bacterium, and in the case of secreting the enzyme derived from the psychrophilic and mesophilic bacterium outside the thermophilic bacterium, a secretory signal sequence. It is preferable that it is further included.
  • polynucleotide sequence that controls the expression examples include a polynucleotide sequence encoding a promoter, a terminator, or a signal peptide.
  • the gene marker can be appropriately selected according to the selection method of the transformant. For example, a gene encoding drug resistance or a gene complementary to auxotrophy can be used.
  • the promoter can be appropriately selected according to the target psychrophilic and mesophilic bacterium-derived enzymes. For example, Hirokazu Suzuki et al., Appl Environ Microbiol. September 2013, 79 (17), p. 5151-5158, Geobacillus kaustophilus, Pgk704 (putative amylose metabolic gene promoter), Pgk1859 (putative serbiose metabolic gene promoter), Pgk1894 (myoinositol metabolic gene promoter), Pgk1899 (myoinositol metabolic gene promoter), Pgk1907 (Putative L-arabinose metabolic gene promoter), Pgk2150 (putative D-galactose metabolic gene promoter), PsigA (dnaG gene, sigA gene promoter); Lin et al., Metab.
  • the DNA encoding the enzyme derived from the psychrotrophic and mesophilic bacterium is operably linked to a promoter, and the thermophilic bacterium into which the expression vector is introduced; It is preferable that the microorganism from which the promoter is derived is closely related.
  • the promoter is preferably a promoter derived from a Gram-positive eubacteria, and a promoter derived from an eubacteria included in the genus Geobacillus and Bacillus More preferably, it is at least one promoter selected from the group consisting of promoters derived from Bacillus subtilis included in the genus.
  • the production method of the expression vector is not particularly limited, and a known method or a method obtained by appropriately modifying or modifying the known method can be appropriately employed.
  • the expression vector is obtained by ligating the promoter, the DNA encoding the enzyme derived from the psychrotrophic bacterium and the mesophilic bacterium, and the terminator, if necessary, into the expression cassette, and introducing the expression cassette into the vector. I can do it.
  • the enzyme and conditions for producing the expression vector are not particularly limited, and commercially available products can be appropriately selected and used.
  • the transformation method for introducing the expression vector into the thermophilic bacterium is not particularly limited, and a known method can be appropriately employed. For example, a microinjection method, an electroporation method, a polyethylene glycol method, a particle gun Method, protoplast fusion method, junction transfer method, and calcium phosphate method can be used.
  • the thermophilic bacterium into which the expression vector is introduced may be, if necessary, one that has already been transformed so as to lack a specific function or a mutant.
  • the second step according to the present invention is a step in which the transformant is cultured and grown at a culture temperature of 50 ° C. or higher. If the culture temperature in the second step is lower than the lower limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic and mesophilic bacterium-derived enzymes. Further, as the culture temperature in the second step, it is possible to further distinguish between the growth stage of the transformant and the expression stage of the enzyme, and the viewpoint that the culture for growing the transformant is easier. Therefore, the temperature is preferably 55 to 87 ° C, more preferably 55 to 65 ° C.
  • the culture temperature in the third step is changed to a temperature lower than 50 ° C. and lower than the culture temperature of the second step by 10 ° C. It is a process of making it express.
  • the culture temperature in the third step exceeds the above upper limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic and mesophilic bacterium-derived enzymes.
  • the culture temperature in the third step is 25 to 45 ° C. from the viewpoint of further distinguishing between the growth stage of the transformant and the expression stage of the enzyme and suppressing the killing of the transformant. It is preferably 30 to 45 ° C, more preferably 40 to 45 ° C.
  • the culture temperature in the third step is not necessarily required to coincide with the optimum growth temperature of the above-mentioned thermophilic bacterium and mesophilic bacterium from which the enzyme to be expressed is derived. Enzymes derived from psychrophilic bacteria and mesophilic bacteria can be sufficiently expressed when the culture temperature in the step is within the above temperature range.
  • the OD 600 of the culture medium for culturing the transformant is 1 or less, more preferably 0.1 to 0.9. In this case, it is preferable to change the culture temperature from the culture temperature in the second step to the culture temperature in the third step. If the OD 600 when changing the culture temperature is less than the lower limit, the amount of expression of the enzyme tends to decrease because of insufficient growth of the transformant. On the other hand, if the OD 600 exceeds the upper limit, Tends to be difficult to express.
  • the OD 600 value refers to the absorbance at 600 nm of a culture solution (including all components contained in the culture system such as culture medium and microorganisms) in which the transformant is cultured.
  • the culture time after changing the culture temperature from the temperature of the second step to the temperature of the third step is that of the thermophile that is the host microorganism.
  • the thermophile that is the host microorganism.
  • Geobacillus genus more preferably, Geobacillus thermoglucosidashius
  • it is preferably 1 to 48 hours, and preferably 3 to 48 hours. More preferably, it is 3 to 24 hours, more preferably 3 to 15 hours.
  • the incubation time after the temperature change is less than the lower limit, the expression level of the enzyme tends to decrease.
  • the upper limit is exceeded, the expression rate decreases and the expression level of the enzyme becomes unstable. There is a tendency.
  • thermophile that is a microorganism
  • other conditions for culturing the transformant are not particularly limited, and the host Depending on the type of thermophile that is a microorganism, it can be selected from known culture conditions or conditions obtained by appropriately modifying or modifying known culture conditions.
  • the target psychrophilic and mesophilic bacterium-derived enzymes can be preferentially expressed while suppressing the growth of transformants using the thermophilic bacterium.
  • the medium is changed after the second step, and the enzyme derived from the psychrophilic and mesophilic bacterium is expressed in the third step. Since it can be selectively obtained in a medium, this medium can be used as a crude enzyme in an enzyme reaction.
  • the activity of an enzyme derived from a thermophilic bacterium as a host microorganism is suppressed in the vicinity of the optimum temperature of the obtained psychrotrophic and mesophilic bacterium-derived enzymes.
  • the culture solution containing the body can be used as it is in the enzyme reaction as a crude enzyme.
  • the enzyme after completion of the culture of the transformant, a solution obtained by recovering the transformant by centrifugation or filtration and disrupting the cells can be used as the crude enzyme. Further, these crude enzymes can be concentrated by an ultrafiltration method or the like, and a preservative or the like can be added to obtain a concentrated enzyme.
  • the crude enzyme or the concentrated enzyme may be purified by using, for example, a salting-out method, an organic solvent precipitation method, a membrane separation method, or a chromatographic separation method alone or in combination of two or more.
  • a salting-out method an organic solvent precipitation method
  • a membrane separation method or a chromatographic separation method alone or in combination of two or more.
  • the enzyme to which the purification tag is added may be purified using a column for purification of the tagged protein.
  • the enzymes derived from psychrophilic and mesophilic bacteria obtained by the production method of the present invention can be used for various enzyme reactions depending on the kind of the enzyme. Although it does not restrict
  • Example 1 ⁇ Isolation of DNA (lacZ)> First, genomes were extracted from BL21 (DE3) (Merck) using DNeasy Blood & Tissue Kit (Qiagen). Using the extracted genome as a template, Escherichia coli ⁇ using HM48 primer (nucleotide sequence described in SEQ ID NO: 1), HM49 primer (nucleotide sequence described in SEQ ID NO: 2) and PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) A sequence encoding galactosidase (lacZ, nucleotide sequence set forth in SEQ ID NO: 3, GeneBank ID: CP001509.3 (335840-332766)) was amplified.
  • HM48 primer nucleotide sequence described in SEQ ID NO: 1
  • HM49 primer nucleotide sequence described in SEQ ID NO: 2
  • PCR enzyme KOD Fx Neo, Toyobo Co., Ltd.
  • the amplified PCR product was purified using QIAquick Spin Gel Extraction Kit (Qiagen), and the purified PCR product and pET28a + (Merck) were respectively obtained with NcoI (Takara Bio) and NotI (Takara Bio). It cut
  • the PCR product (68 ng) and pET28a + (233 ng) after cleavage and purification were ligated using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.) and introduced into 200 ⁇ l of E. coli JM109 chemical competent cell.
  • Transformants were selected on an LB medium plate (25 ⁇ g / ml kanamycin), inoculated into 3 ml of LB medium (25 ⁇ g / ml kanamycin) and grown.
  • the pESG23 plasmid containing lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • pNW33N plasmid (nucleotide sequence described in SEQ ID NO: 4, obtained from Bacillus Genetic Stock Center) was cleaved with HindIII (Takara Bio) and purified using QIAquick Spin Gel Extraction Kit (Qiagen). Also, Kenji Tsuge et al., Nucleic Acids Res.
  • Transformants were selected on an LB medium plate (25 ⁇ g / ml chloramphenicol), inoculated into 3 ml of LB medium (25 ⁇ g / ml chloramphenicol) and grown.
  • the pNW (SfiI) plasmid containing the SfiI site was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • HM51 primer nucleotide sequence described in SEQ ID NO: 7
  • HM52H primer primer for adding His6 tag, nucleotide sequence described in SEQ ID NO: 8
  • lacZ was amplified using PCR enzyme (KOD plus ver.2, Toyobo Co., Ltd.) (PCR2).
  • PCR products amplified by PCR1 and PCR2 were each subjected to agarose gel electrophoresis to confirm the length, and then purified using QIAquick Spin Gel Extraction Kit (Qiagen).
  • Qiagen QIAquick Spin Gel Extraction Kit
  • PCR1 product 100 ng
  • PCR2 product 100 ng
  • HM05b primer 100 ng
  • HM52H primer 100 ng
  • PCR enzyme KOD plus ver. 2, Toyobo
  • Step 1 98 ° C. for 10 seconds
  • Step 2 60 ° C.
  • Fusion PCR was performed under the conditions of 30 seconds
  • Step 3 68 ° C. for 4 minutes
  • the temperature increase rate from Step 2 to Step 3: 0.1 ° C./second 35 cycles to prepare an expression cassette in which ldh and lacZ were fused.
  • the pNW (SfiI) plasmid obtained above was cleaved with HindIII, mixed with the expression cassette, purified using QIAquick Spin Gel Extraction Kit (Qiagen), and then Gibson Assembly Master Mix (2x) And introduced into 200 ⁇ l of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (25 ⁇ g / ml chloramphenicol), inoculated into 3 ml of LB medium (25 ⁇ g / ml chloramphenicol) and grown. A pESG21H plasmid (nucleotide sequence described in SEQ ID NO: 9) containing ldh and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • thermophilic bacteria competent cells As a host microorganism, a thermophilic bacterium belonging to the genus Geobacillus ordered from Bacillus Genetic Stock Center (Geobacillus thermoglocosidius DSM2542, optimum growth temperature: 55 ° C.) was used. Production and transformation of thermophilic bacteria competent cells is described in Mark P. et al. Taylor et al., Plasmid, July 2008, 60 (1), p. According to the method described in 45-52:
  • thermophilic bacteria competent cells The thermophile was added to a TGP medium plate (tryptone: 17 g / l, soyton: 3 g / l, K 2 HPO 4 : 2.5 g / l, NaCl: 5 g / l, sodium pyruvate: 4 g / l, glycerol: 4 ml / l l, Agar: 15 g / l) and after overnight culture at 60 ° C., the obtained colony was treated with 1 ml of TGP medium (tryptone: 17 g / l, soyton: 3 g / l, K 2 HPO 4 : 2.5 g / l, NaCl: 5 g / l, sodium pyruvate: 4 g / l, glycerol: 4 ml / l), cultured at 60 ° C.
  • TGP medium plate tryptone: 17 g / l, soyton: 3 g /
  • the mixture was cooled on ice for 10 minutes. Thereafter, the cells were collected by centrifugation at 8000 rpm for 5 minutes, suspended in an electroporation buffer (0.5 M sorbitol, 0.5 M mannitol, 10% glycerol), and centrifuged at 8000 rpm for 5 minutes to collect the cells four times. Repeated. Thereafter, the suspension was suspended in 1.5 ml of electroporation buffer, dispensed in 60 ⁇ l aliquots, and stored at ⁇ 80 ° C.
  • electroporation buffer 0.5 M sorbitol, 0.5 M mannitol, 10% glycerol
  • thermophilic bacterium competent cell 60 ⁇ l obtained above and the pESG21H plasmid (500 ng) were mixed, put into a 0.1 cm cuvette, and then using a Gene Pulser Xcell (BioRad), 2500 V, 10 ⁇ F, 600 ⁇ . Electrical stimulation was given. Thereafter, 1 ml of TGP medium was added, transferred to a 14 ml polypropylene round bottom tube (FALCON), shaken at 60 ° C. for 2 hours, and then applied to a TGP medium plate (10 ⁇ g / ml chloramphenicol) at 60 ° C. Cultured overnight.
  • FALCON polypropylene round bottom tube
  • the obtained colonies (4 colonies) were each inoculated into 3 ml of LB medium and cultured at 60 ° C. overnight, and then an equal amount of 80% glycerol was added to prepare a glycerol stock of the transformant. Saved with.
  • ⁇ Culture of transformant> a part of the glycerol stock of the transformant obtained above was placed in LB medium (25 ⁇ g / ml chloramphenicol) and cultured overnight.
  • 120 ml of LB medium (25 ⁇ g / ml chloramphenicol) was placed in a 500 ml Erlenmeyer flask and inoculated with 1 ml of an overnight culture.
  • the incubator BR-43FL, Taitec Co., Ltd.
  • the evaluation was performed by visually observing the appearance (color) of the culture solution after incubation, and the following criteria: 0: Orange (no blue color is confirmed (the color of the medium is the same as that without X-gal)) 1: Yellow (slightly blue but almost the same as when X-gal was not added) 2: Yellowish green (blue is confirmed) 3: Green 4: Performed based on blue. In addition, it can be judged that the enzyme is expressing more, so that the numerical value of evaluation is large.
  • Example 2 In culturing the transformant, the culture was performed in the same manner as in Example 1 except that the culture temperature in the third step was 37 ° C. After starting the culture in the third step (after changing the culture temperature to 37 ° C.), OD 600 of the culture solution after culturing for 0, 1.5, 3, 24 hours was measured to obtain a growth curve. Further, ⁇ -galactosidase activity was evaluated in the same manner as in Example 1 except that the incubation temperature after adding X-gal was 37 ° C.
  • Example 1 In the culture of the transformant, the culture was performed in the same manner as in Example 1 except that the culture temperature in the third step was kept at 60 ° C. following the second step. Also, OD after culturing at ⁇ 3.5, ⁇ 1, 0, 1.5, 3, 24 hours, assuming that the culture start time of the second step is ⁇ 5 hours and the culture start time of the third step is 0 hours. 600 is measured to obtain a growth curve. Further, ⁇ -galactosidase activity was evaluated in the same manner as in Example 1 except that the incubation temperature after addition of X-gal was 60 ° C.
  • FIG. 2A is a photograph showing the appearance when the ⁇ -galactosidase activity evaluation is performed on the culture solution at the start of the culture in the third step of Comparative Example 1 (after 0 hour culture).
  • FIG. 2B is a photograph showing the external appearance when ⁇ -galactosidase activity evaluation was performed on the culture solution after 3 hours of culture from the start of the culture in the third step of Example 1, and the third example of Examples 1-2 and Comparative Example 1 was used.
  • FIG. 2C The photographs showing the external appearance when the ⁇ -galactosidase activity evaluation is performed on the culture solution after 24 hours of cultivation from the start of the cultivation in the step are shown in FIG. 2C, respectively.
  • Example 3 ⁇ Isolation of DNA (lacZ)> In the same manner as in Example 1, a pESG23 plasmid containing lacZ was obtained.
  • the cut and purified pGAM46 and the insert were mixed, ligated using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.), and introduced into 200 ⁇ l of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (100 ⁇ g / ml ampicillin), inoculated into 3 ml of LB medium (100 ⁇ g / ml ampicillin) and grown.
  • a pGAM46 (SfiI) plasmid containing the SfiI site was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • a HindIII-promoter-fw primer (described in SEQ ID NO: 11) using a plasmid containing a putative amylose metabolic gene promoter (Pgk704 promoter (Pgk704), nucleotide sequence described in SEQ ID NO: 10) derived from the Geobacillus kaustophilus HTA426 genome as a template.
  • Pgk704 was amplified using a promoter-rv primer (nucleotide sequence described in SEQ ID NO: 12) and a PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) (PCR1).
  • promoter-bGalE-fw primer (nucleotide sequence described in SEQ ID NO: 13)
  • HindIII-H6-bGalE-rv primer (described in SEQ ID NO: 14) LacZ was amplified using (nucleotide sequence) and PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) (PCR2).
  • PCR products amplified by PCR1 and PCR2 were each subjected to agarose gel electrophoresis to confirm the length, and then purified using QIAquick Spin Gel Extraction Kit (Qiagen).
  • the fusion PCR was performed using PCR1 product and PCR2 product after purification, HindIII-promoter-fw primer, HindIII-H6-bGalE-rv primer, PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.), and Pgk704 and lacZ were fused.
  • a cassette was made.
  • the pNW (SfiI) plasmid was cleaved with HindIII, treated with CIAP (Alkaline Phosphatase (Calf intestine), Takara Bio), purified with QIAquick Spin Gel Extraction Kit (Qiagen), and purified with H in III. It mixed with the said expression cassette refine
  • CIAP Alkaline Phosphatase (Calf intestine), Takara Bio
  • QIAquick Spin Gel Extraction Kit Qiagen
  • Transformants were selected on an LB medium plate (34 ⁇ g / ml chloramphenicol), inoculated into 3 ml of LB medium (34 ⁇ g / ml chloramphenicol) and grown.
  • a pESG28 plasmid containing Pgk704 and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • HM58 primer nucleotide sequence described in SEQ ID NO: 15
  • HM60 primer nucleotide sequence described in SEQ ID NO: 16
  • PCR enzyme KOD plus Ver. 2, Toyobo Co., Ltd.
  • the PCR3 product amplified by PCR3 was subjected to agarose gel electrophoresis to confirm the length, and then purified using a QIAquick Spin Gel Extraction Kit (Qiagen).
  • the pGAM46 (SfiI) plasmid obtained above was cleaved with HindIII, purified using QIAquick Spin Gel Extraction Kit (Qiagen), mixed with the PCR3 product purified in the same manner, and In-Fusion HD Cloning.
  • the cells were ligated using Kit (Takara Bio Inc.) and introduced into 200 ⁇ l of E. coli JM109 chemical competent cell.
  • Transformants were selected on an LB medium plate (100 ⁇ g / ml ampicillin), inoculated into 3 ml of LB medium (100 ⁇ g / ml ampicillin) and grown.
  • a pESG32 plasmid containing Pgk704 and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
  • coli BR408 (pESG32) and Geobacillus kaustophilus MK242 were mixed at a ratio of 2: 8 (mass ratio), and the bacteria were adsorbed on a membrane filter (pore size: 0.2 ⁇ m, Omnipore, Merck Millipore) by filtration under reduced pressure. This was placed on an LB agar medium and cultured at 37 ° C. for 4 to 6 hours.
  • the obtained colony of MK242 (pESG32) was cultured in 200 ml of LB medium, and 200 ⁇ l of the culture solution was inoculated into 200 ml of LB medium and cultured four times, and then 1 ml of the culture solution was centrifuged. The precipitate was suspended in 1 ml of ultrapure water. 50 ⁇ l or 250 ⁇ l of suspension was cultured for 4-6 hours in 5 ml of selective minimal medium 1 (medium supplemented with 1 ⁇ g / ml uracil, 50 ⁇ g / ml 5-fluoroorotic acid to the minimal medium).
  • 1 ⁇ l or 100 ⁇ l of the culture solution is applied to a plate of selective minimal medium 2 (medium supplemented with 10 ⁇ g / ml uracil, 50 ⁇ g / ml 5-fluoroorotic acid to the minimal medium), and cultured at 60 ° C. for about 1 day.
  • selective minimal medium 2 medium supplemented with 10 ⁇ g / ml uracil, 50 ⁇ g / ml 5-fluoroorotic acid to the minimal medium
  • the obtained colonies were further applied to the selective minimal medium plate and the LB medium plate, respectively, and the colonies that did not grow on the minimal selective medium were selected to produce glycerol stocks from the corresponding colonies of the LB medium,
  • the following transformants were cultured and used for ⁇ -galactosidase activity evaluation.
  • the colonies that did not grow on the minimal selection medium are those that do not contain pGAM46-derived sequences among MK242 (pESG32), that is, Geobacillus kaustophilus MK242 (MK242 (Pgk704 / lacZ)) in which Pgk704 and lacZ are integrated into the genome. It is.
  • Example 4 Transformants were cultured in the same manner as in Example 3 except that the culture temperature in the third step was 37 ° C., and a growth curve was obtained. In addition, ⁇ -galactosidase activity was evaluated in the same manner as in Example 3 except that the incubation temperature after adding X-gal was 37 ° C.
  • Example 2 In the culture of the transformant, the transformant was cultured in the same manner as in Example 3 except that the culture temperature in the third step was kept at 60 ° C. following the second step. OD 600 after culturing at ⁇ 2.5, ⁇ 1, 0, 1.5, 3, 6, 24, and 30 hours, assuming that the culture start time is ⁇ 2.5 hours and the culture start time of the third step is 0 hours. was measured to obtain a growth curve. Furthermore, ⁇ -galactosidase activity was evaluated in the same manner as in Example 3 except that the incubation temperature after addition of X-gal was 60 ° C.
  • FIG. Table 2 shows the evaluation results of ⁇ -galactosidase activity (incubation time: 1 hour).
  • FIG. 4A shows a photograph showing an external appearance when ⁇ -galactosidase activity evaluation (incubation time: 1 hour) is performed on the culture solution at the start of culture (after 0 hour culture) in the third step of Comparative Example 2.
  • FIG. 4B is a photograph showing the external appearance when the ⁇ -galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2.
  • FIG. 5B is a photograph showing the external appearance when the ⁇ -galactosidase activity evaluation (incubation time: 3 hours) was performed on the culture solution after 3 hours of cultivation from the start of the third step in Examples 3 to 4 and Comparative Example 2. Respectively.
  • a psychrophilic bacterium and a mesophilic temperature capable of separating the growth stage of a transformant introduced with DNA encoding an enzyme derived from psychrophilic bacteria and mesophilic bacteria and the expression stage of the enzyme. It is possible to provide a method for producing a bacterium-derived enzyme.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A method for producing an enzyme derived from a psychrophilic or mesophilic microorganism, said method comprising: a first step for introducing, into a thermophilic microorganism having an optimum growth temperature of 50oC or higher, a DNA encoding an enzyme derived from at least one kind of microorganism selected from among a psychrophilic microorganism and a mesophilic microorganism, the optimum growth temperature of which is 50oC or lower and lower by at least 10oC than the optimum growth temperature of the thermophilic microorganism,to thereby obtain a transformant; a second step for culturing and growing the transformant at a culture temperature of 50oC or higher; and a third step for, after the second step, changing the culture temperature to 50oC or lower and lower by at least 10oC than the culture temperature in the second step to thereby express the enzyme.

Description

低温菌及び中温菌由来酵素の製造方法Process for producing thermophilic bacteria and enzymes derived from mesophilic bacteria
 本発明は低温菌及び中温菌由来酵素の製造方法に関する。 The present invention relates to a method for producing enzymes derived from thermophilic bacteria and mesophilic bacteria.
 酵素は、低エネルギーで有機物を合成・分解することができ、化学合成のような副生成物を発生させないため、食品、医薬品、化粧品及び機能性材料等の様々な分野において広く用いられている。酵素を製造する方法としては、各種生物体内の酵素を抽出する方法の他、目的とする酵素をコードするDNAを宿主微生物に導入した形質転換体を培養して当該酵素を発現させる方法が知られており、前記宿主微生物としては、大腸菌や酵母菌等が従来から汎用されている。しかしながら、このような宿主微生物を用いた方法では、目的とする酵素に加えて、当該宿主微生物由来の酵素も同時に発現・活性化してしまうため、目的とする酵素の発現を制御して酵素を効率良く製造する方法の開発が望まれている。 Enzymes are widely used in various fields such as foods, pharmaceuticals, cosmetics and functional materials because they can synthesize and decompose organic substances with low energy and do not generate by-products such as chemical synthesis. As a method for producing an enzyme, in addition to a method for extracting an enzyme in various organisms, a method for culturing a transformant in which a DNA encoding a target enzyme is introduced into a host microorganism and expressing the enzyme is known. As the host microorganism, Escherichia coli, yeast and the like have been widely used conventionally. However, in such a method using a host microorganism, in addition to the target enzyme, an enzyme derived from the host microorganism is also expressed and activated at the same time. Therefore, the expression of the target enzyme is controlled to make the enzyme efficient. Development of a method for manufacturing well is desired.
 形質転換体を用いた酵素の製造方法としては、例えば、特開2011-160778号公報(特許文献1)において、耐熱性酵素をコードしている遺伝子を用いて抗酸菌を形質転換することにより形質転換体を得る工程と前記形質転換体を加熱処理することにより固定化耐熱性酵素を得る工程とを含む製造方法が記載されている。しかしながら、特許文献1に記載されている方法は超高熱菌又は好熱菌に由来する耐熱性酵素の製造方法であり、得られた酵素は高温で反応させる必要があった。 As a method for producing an enzyme using a transformant, for example, in Japanese Patent Application Laid-Open No. 2011-160778 (Patent Document 1), a mycobacteria is transformed using a gene encoding a thermostable enzyme. A production method including a step of obtaining a transformant and a step of obtaining an immobilized thermostable enzyme by heat-treating the transformant is described. However, the method described in Patent Document 1 is a method for producing a thermostable enzyme derived from a hyperthermophilic bacterium or a thermophilic bacterium, and the obtained enzyme has to be reacted at a high temperature.
特開2011-160778号公報JP 2011-160778 A
 本発明は、上記従来技術の有する課題に鑑みてなされたものであり、低温菌及び中温菌に由来する酵素をコードするDNAを導入した形質転換体の増殖段階と前記酵素の発現段階とを分けることができる低温菌及び中温菌由来酵素の製造方法を提供することを目的とする。 The present invention has been made in view of the above-described problems of the prior art, and separates the growth stage of transformants into which DNAs encoding enzymes derived from psychrophilic and mesophilic bacteria are introduced and the expression stage of the enzyme. It is an object of the present invention to provide a method for producing a thermophilic bacterium and an enzyme derived from a mesophilic bacterium.
 本発明者らは、上記目的を達成すべく鋭意研究を重ねた結果、至適増殖温度が高温(50℃以上)の好熱菌に、至適増殖温度が低い(50℃以下かつ前記好熱菌の至適増殖温度よりも10℃以上低い)低温菌及び中温菌からなる群から選択される少なくとも1種の微生物に由来する酵素(低温菌及び中温菌由来酵素)をコードするDNAを導入して得られた形質転換体を、先ず高温(50℃以上)で培養し、次いで低温(50℃以下かつ前記高温よりも10℃以上低い温度)で培養することによって、前記形質転換体の増殖段階と前記低温菌及び中温菌由来酵素の発現段階とを分けることができることを見い出し、本発明を完成するに至った。 As a result of intensive studies to achieve the above-mentioned object, the present inventors have found that thermophilic bacteria having an optimum growth temperature are high (50 ° C. or higher) and that the optimum growth temperature is low (50 ° C. or lower and the thermophilic). A DNA encoding an enzyme derived from at least one microorganism selected from the group consisting of a psychrotrophic bacterium and a mesophilic bacterium (lower than the optimum growth temperature of the bacterium by 10 ° C. or more). The transformant thus obtained is first cultured at a high temperature (50 ° C. or higher), and then cultured at a low temperature (50 ° C. or lower and 10 ° C. or higher). And the expression stage of the enzyme derived from the psychrophilic bacterium and the mesophilic bacterium are found out, and the present invention has been completed.
 すなわち、本発明の低温菌及び中温菌由来酵素の製造方法は、
 至適増殖温度が50℃以上である好熱菌に、至適増殖温度が50℃以下かつ前記好熱菌の至適増殖温度よりも10℃以上低い温度である低温菌及び中温菌からなる群から選択される少なくとも1種の微生物に由来する酵素をコードするDNAを導入して、形質転換体を得る第1の工程と、
 50℃以上の培養温度で前記形質転換体を培養して増殖させる第2の工程と、
 第2の工程の後、培養温度を50℃以下かつ第2の工程の培養温度よりも10℃以上低い温度に変えて前記酵素を発現させる第3の工程と、
を含むものである。
That is, the method for producing the psychrophilic and mesophilic bacterium-derived enzymes of the present invention comprises:
A group consisting of a thermophilic bacterium having an optimal growth temperature of 50 ° C. or higher, a thermophilic bacterium having an optimal growth temperature of 50 ° C. or lower and a temperature lower by 10 ° C. or more than the optimal growth temperature of the thermophilic bacterium A first step of obtaining a transformant by introducing DNA encoding an enzyme derived from at least one microorganism selected from:
A second step of culturing and growing the transformant at a culture temperature of 50 ° C. or higher;
After the second step, a third step of expressing the enzyme by changing the culture temperature to 50 ° C. or lower and a temperature lower by 10 ° C. or higher than the culture temperature of the second step;
Is included.
 本発明の低温菌及び中温菌由来酵素の製造方法においては、第2の工程の培養温度が55~87℃であることが好ましく、また、第3の工程の培養温度が25~45℃であることが好ましい。さらに、本発明の低温菌及び中温菌由来酵素の製造方法においては、前記形質転換体を培養する培養液のOD600が1以下であるときに第2の工程の培養温度から第3の工程の培養温度に変えることが好ましい。 In the method for producing a thermophilic bacterium and mesophilic bacterium-derived enzyme of the present invention, the culture temperature in the second step is preferably 55 to 87 ° C., and the culture temperature in the third step is 25 to 45 ° C. It is preferable. Furthermore, in the method for producing a thermophilic bacterium and mesophilic bacterium-derived enzyme of the present invention, when the OD 600 of the culture medium for culturing the transformant is 1 or less, the culturing temperature of the second step is changed to the third step. It is preferable to change the culture temperature.
 本発明の酵素反応方法は、上記本発明の低温菌及び中温菌由来酵素の製造方法で得られた酵素と前記酵素の基質とを接触させて反応せしめるものである。 The enzyme reaction method of the present invention is a method in which the enzyme obtained by the above-described method for producing a thermophilic bacterium and a mesophilic bacterium-derived enzyme of the present invention is brought into contact with a substrate of the enzyme and reacted.
 なお、本発明において、「至適増殖温度」とは、微生物が最も急速に増殖する温度を指し、各温度で微生物を一定時間培養して得られる比増殖速度が最も大きくなる温度をその微生物の至適増殖温度とすることができる。 In the present invention, the “optimum growth temperature” refers to the temperature at which a microorganism grows most rapidly, and the temperature at which the specific growth rate obtained by culturing the microorganism for a certain period of time at each temperature is the highest. Optimal growth temperature can be achieved.
 本発明によれば、低温菌及び中温菌に由来する酵素をコードするDNAを導入した形質転換体の増殖段階と前記酵素の発現段階とを分けることができる低温菌及び中温菌由来酵素の製造方法を提供することが可能となる。そのため、例えば、低温菌及び中温菌由来酵素が分泌系で発現されるように形質転換体を作製し、高温で増殖させた後に培地を交換してから培養温度を低温に変えることにより、目的の低温菌及び中温菌由来酵素を選択的に培地中に得ることができるため、酵素の回収・精製が容易となる。また、得られる低温菌及び中温菌由来酵素の最適温度付近では、宿主微生物である好熱菌由来の酵素の活性が抑制されるため、形質転換体を含む培養液をそのまま酵素反応に用いることが可能となる。 According to the present invention, a method for producing a psychrophilic bacterium and a mesophilic bacterium-derived enzyme capable of separating a growth stage of a transformant introduced with DNA encoding an enzyme derived from a psychrophilic bacterium and a mesophilic bacterium and an expression stage of the enzyme. Can be provided. Therefore, for example, by producing a transformant so that the enzyme derived from the psychrotrophic and mesophilic bacterium is expressed in the secretory system, after growing at a high temperature, the medium is changed, and then the culture temperature is changed to a low temperature. Since an enzyme derived from a thermophilic bacterium and a mesophilic bacterium can be selectively obtained in a medium, the enzyme can be easily recovered and purified. In addition, since the activity of the enzyme derived from the thermophilic bacterium that is the host microorganism is suppressed near the optimum temperature of the enzyme derived from the thermophilic bacterium and mesophilic bacterium obtained, the culture solution containing the transformant can be used for the enzyme reaction as it is. It becomes possible.
実施例1~2及び比較例1において得られた増殖曲線である。2 is a growth curve obtained in Examples 1 and 2 and Comparative Example 1. 比較例1の第3の工程の培養開始時の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を撮影した写真である。It is the photograph which image | photographed the external appearance when (beta) -galactosidase activity evaluation was implemented about the culture solution at the time of the culture | cultivation start of the 3rd process of the comparative example 1. FIG. 実施例1~2及び比較例1の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を撮影した写真である。FIG. 3 is a photograph of the appearance when β-galactosidase activity was evaluated for culture broths cultured for 3 hours from the start of culture in the third step of Examples 1 and 2 and Comparative Example 1. FIG. 実施例1~2及び比較例1の第3の工程の培養開始から24時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を撮影した写真である。FIG. 3 is a photograph of the appearance when β-galactosidase activity evaluation was performed on culture broths cultured for 24 hours from the start of culture in the third step of Examples 1 and 2 and Comparative Example 1. FIG. 実施例3~4及び比較例2において得られた増殖曲線である。4 is a growth curve obtained in Examples 3 to 4 and Comparative Example 2. 比較例2の第3の工程の培養開始時の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を撮影した写真である。It is the photograph which image | photographed the external appearance when (beta) -galactosidase activity evaluation (incubation time: 1 hour) was implemented about the culture solution at the time of the culture | cultivation start of the 3rd process of the comparative example 2. FIG. 実施例3~4及び比較例2の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を撮影した写真である。FIG. 4 is a photograph of the appearance when β-galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. . 実施例3~4及び比較例2の第3の工程の培養開始から6時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を撮影した写真である。FIG. 4 is a photograph of the appearance when β-galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 6 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. . 比較例2の第3の工程の培養開始時の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:3時間)を実施したときの外観を撮影した写真である。It is the photograph which image | photographed the external appearance when (beta) -galactosidase activity evaluation (incubation time: 3 hours) was implemented about the culture solution at the time of the culture | cultivation start of the 3rd process of the comparative example 2. FIG. 実施例3~4及び比較例2の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:3時間)を実施したときの外観を撮影した写真である。FIG. 3 is a photograph of the appearance when β-galactosidase activity evaluation (incubation time: 3 hours) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. .
 以下、本発明をその好適な実施形態に即して詳細に説明する。 Hereinafter, the present invention will be described in detail on the basis of preferred embodiments thereof.
 本発明の低温菌及び中温菌由来酵素の製造方法は、
 至適増殖温度が50℃以上である好熱菌に、至適増殖温度が50℃以下かつ前記好熱菌の至適増殖温度よりも10℃以上低い温度である低温菌及び中温菌からなる群から選択される少なくとも1種の微生物に由来する酵素(低温菌及び中温菌由来酵素)をコードするDNAを導入して、形質転換体を得る第1の工程と、
 50℃以上の培養温度で前記形質転換体を培養して増殖させる第2の工程と、
 第2の工程の後、培養温度を50℃以下かつ第2の工程の培養温度よりも10℃以上低い温度に変えて前記酵素を発現させる第3の工程と、
を含む。
The method for producing the thermophilic bacterium and the mesophilic bacterium-derived enzyme of the present invention comprises:
A group consisting of a thermophilic bacterium having an optimal growth temperature of 50 ° C. or higher, a thermophilic bacterium having an optimal growth temperature of 50 ° C. or lower and a temperature lower by 10 ° C. or more than the optimal growth temperature of the thermophilic bacterium A first step of obtaining a transformant by introducing DNA encoding an enzyme (an enzyme derived from a thermophilic bacterium or an enzyme derived from a mesophilic bacterium) selected from at least one microorganism selected from:
A second step of culturing and growing the transformant at a culture temperature of 50 ° C. or higher;
After the second step, a third step of expressing the enzyme by changing the culture temperature to 50 ° C. or lower and a temperature lower by 10 ° C. or higher than the culture temperature of the second step;
including.
 本発明において、「好熱菌」とは、至適増殖温度が50℃以上である微生物である。このような好熱菌としては、好熱性真正細菌、超好熱性真正細菌、好熱性古細菌及び超好熱性古細菌が挙げられ、発現が容易である観点からは、宿主微生物として真性細菌を用い、下記の低温菌及び中温菌由来酵素として真正細菌由来酵素を発現させることが好ましいことから、好熱性真正細菌又は超好熱性真正細菌であることがより好ましい。なお、本発明において、好熱性とは、微生物の至適増殖温度が50℃以上80℃未満であることを指し、超好熱性とは、微生物の至適増殖温度が80℃以上であることを指す。 In the present invention, a “thermophilic bacterium” is a microorganism having an optimal growth temperature of 50 ° C. or higher. Examples of such thermophilic bacteria include thermophilic eubacteria, hyperthermophilic eubacteria, thermophilic archaea and hyperthermophilic archaea. From the viewpoint of easy expression, eubacteria are used as host microorganisms. Since it is preferable to express an eubacteria-derived enzyme as an enzyme derived from the following thermophilic bacteria and mesophilic bacteria, it is more preferably a thermophilic eubacteria or a hyperthermophilic eubacteria. In the present invention, thermophilic means that the optimum growth temperature of the microorganism is 50 ° C. or more and less than 80 ° C., and super thermophilicity means that the optimum growth temperature of the microorganism is 80 ° C. or more. Point to.
 前記好熱性真正細菌及び超好熱性真正細菌としては、公的機関から入手可能であり、形質転換体の作製の実績がある、又は形質転換体の作製が比較的容易である傾向にある観点から、ゲオバチルス属、バチルス属、サーマス属、サーモトガ属、シュードサーモトガ属、サーモデスルフォバクテリウム属、アクウィフェクス属であることが好ましく、ゲオバチルス属、バチルス属、サーマス属、サーモトガ属であることがより好ましく、ゲオバチルス属であることが特に好ましい。 From the viewpoint that the thermophilic eubacteria and the hyperthermophilic eubacteria are available from public institutions, have a track record of producing transformants, or tend to be relatively easy to produce transformants. , Geobacillus genus, Bacillus genus, Thermus genus, Thermotoga genus, Pseudothermotoga genus, Thermodessulfobacteria genus, Akwifex genus, Geobacillus genus, Bacillus genus, Thermus genus, Thermotoga Particularly preferred is Geobacillus.
 前記ゲオバチルス属としては、ゲオバチルス・サーモグルコシダシウス(Geobacillus thermoglucosidasius、至適増殖温度:55℃)、ゲオバチルス・カウストフィラス(Geobacillus kaustophilus、至適増殖温度:55℃)、ゲオバチルス・ステアロサーモフィラス(Geobacillus stearothermophilus、至適増殖温度:55℃)、ゲオバチルス・サブテラネウス(Geobacillus subterraneus、至適増殖温度:55℃)、ゲオバチルス・ウゼネンシス(Geobacillus uzenensis、至適増殖温度:55℃)、ゲオバチルス・サーモカテニュラタス(Geobacillus thermocatenulatus、至適増殖温度:60℃)、ゲオバチルス・サーモデニトリフィカンス(Geobacillus thermodenitrificans、至適増殖温度:60℃)、ゲオバチルス・サーモレオボランス(Geobacillus thermoleovorans、至適増殖温度:60℃)が挙げられる。 Examples of the genus Geobacillus include Geobacillus thermoglucosidasis (optimum growth temperature: 55 ° C.), Geobacillus kaustophilus (optimum growth temperature: 55 ° C.), Geobacillus s. stearothermophilus, optimal growth temperature: 55 ° C., Geobacillus subterraneus (optimal growth temperature: 55 ° C.), Geobacillus uzenensis, optimal growth temperature: 55 ° C. Geobacillus thermocate ulatas, optimal growth temperature: 60 ° C.), Geobacillus thermodenitificans, optimal growth temperature: 60 ° C., Geobacillus thermoreovorans, optimal growth temperature: 60 ° C. Can be mentioned.
 前記バチルス属としては、バチルス・サーマンタルクティカス(Bacillus thermantarcticus、至適増殖温度:55℃)が挙げられ、前記サーマス属としては、サーマス・サーモフィラス(Thermus thermophilus、至適増殖温度:75℃)、サーマス・アクアティカス(Thermus aquaticus、至適増殖温度:70℃)が挙げられる。 Examples of the genus Bacillus include Bacillus thermanticus (Bacillis thermalarticus, optimal growth temperature: 55 ° C.). Examples of the Thermus genus include Thermos thermophilus (Thermus thermophilus, optimal growth temperature: 75 ° C.), Thermus aquaticus (Thermus aquaticus, optimal growth temperature: 70 ° C.).
 また、前記サーモトガ属としては、サーモトガ・マリティマ(Thermotoga maritima 至適増殖温度:80℃)、サーモトガ・ナフトフィラ(Thermotoga naphthophila、至適増殖温度:80℃)、サーモトガ・ネアポリタナ(Thermotoga neapolitana、至適増殖温度:85℃)、サーモトガ・ペトロフィラ(Thermotoga petrophila、至適増殖温度:80℃)が挙げられ、前記シュードサーモトガ属としては、シュードサーモトガ・レティンガエ(Pseudothermotoga lettingae、至適増殖温度:65℃)が挙げられる。 Further, as the genus Thermotoga, Thermotoga maritima (Thermotoga maritima (optimum growth temperature: 80 ° C.), Thermotoga naphtophyla (Optimum growth temperature: 80 ° C.), Thermotoga neapolitana (therma tomato temperature) : Thermotoga petrophila (Thermotoga petrophila, optimal growth temperature: 80 ° C), and the Pseudothermotoga retingae (Pseudothermotoga lettingae, optimal growth temperature: 65 ° C). Can be mentioned.
 さらに、前記サーモデスルフォバクテリウム属としては、サーモデスルフォバクテリウム・コムネ(Thermodesulfobacterium commune、至適増殖温度:70℃)が挙げられ、前記アクウィフェクス属としては、アクウィフェクス・アエオリカス(Aquifex aeolicus、至適増殖温度:85℃)、アクウィフェクス・ピロフィラス(Aquifex pyrophilus、至適増殖温度:85℃)が挙げられる。 Furthermore, examples of the genus Thermodesulfobacterium include Thermodesulfobacterium commune (optimum growth temperature: 70 ° C.). As the genus Aquifex, Aquifex aeolicus (optimus aeolicus) is optimal. Growth temperature: 85 ° C.) and Aquifex pyrophilus (optimum growth temperature: 85 ° C.).
 前記好熱性古細菌及び超好熱性古細菌としては、公的機関から入手可能であり、形質転換体の作製の実績がある、又は形質転換体の作製が比較的容易である傾向にある観点から、アエロパイラム属、アルカエオグロバス属、メタノカルドコッカス属、メタノサーモバクター属、ピロコッカス属、スルフォロバス属であることが好ましい。前記アエロパイラム属としては、アエロパイラム・ペルニクス(Aeropyrum pernix、至適増殖温度:90℃)が挙げられ、前記アルカエオグロバス属としては、アルカエオグロバス・フルギダス(Archaeoglobus fulgidus、至適増殖温度:85℃)が挙げられ、前記メタノカルドコッカス属としては、メタノカルドコッカス・ヤナシ(Methanocaldococcus jannaschii、至適増殖温度:80℃)が挙げられ、前記メタノサーモバクター属としては、メタノサーモバクター・サームオートトロフィカス(Methanothermobacter thermautotrophicus、至適増殖温度:65℃)が挙げられる。 From the viewpoint that the thermophilic archaea and the hyperthermophilic archaea are available from public institutions, have a track record of producing transformants, or tend to be relatively easy to produce transformants. Aeropyram genus, Alcaeoglobus genus, Methanocordococcus genus, Methanothermobacter genus, Pyrococcus genus, and Sulfolobas genus are preferable. Examples of the genus Aeropyrum include Aeropyrum pernicus (optimum growth temperature: 90 ° C.), and examples of the genus Alcaeoglobus include Archaeoglobus fulgidus (optimum growth temperature: 85). The Methanocordococcus genus includes Methanocardococcus jannaschii (optimum growth temperature: 80 ° C.), and the Methanothermobacter genus includes the Methanothermobacter thermoautotro. And Ficus (Methanotherbacter thermotrophicus, optimal growth temperature: 65 ° C.).
 また、前記ピロコッカス属としては、ピロコッカス・フリオサス(Pyrococcus furiosus、至適増殖温度:97℃)、ピロコッカス・ホリコシ(Pyrococcus horikoshii、至適増殖温度:95℃)、ピロコッカス・アビシ(Pyrococcus abysii、至適増殖温度:90℃)が挙げられ、前記スルフォロバスとしては、スルフォロバス・ソルファタリカス(Sulfolobus solfataricus、至適増殖温度:70℃)、スルフォロバス・トコダイ(Sulfolobus tokodaii、至適増殖温度:75℃)が挙げられる。 Examples of the Pyrococcus genus include Pyrococcus furiosus (Pyrococcus furiosus, optimal growth temperature: 97 ° C.), Pyrococcus horikoshi (Pyrococcus horikoshii, optimal growth temperature: 95 ° C.), Pyrococcus abyssi (Pyrococcus, optimal growth). Examples of the sulfolobus include Sulfolobus solfataricus (Sulfobus solfataricus, optimum growth temperature: 70 ° C.), Sulfolobus tokodaii, optimum growth temperature: 75 ° C. .
 本発明に係る好熱菌の至適増殖温度としては、50℃以上であることが必要である。好熱菌の至適増殖温度が前記下限未満であると、形質転換体の増殖段階と酵素の発現段階とを分けることが困難となる。また、前記好熱菌の至適増殖温度としては、形質転換体の増殖段階と酵素の発現段階とをより区別することができ、かつ、形質転換体を増殖させるための培養がより容易であるという観点から、55~87℃であることが好ましく、55~65℃であることがより好ましい。 The optimum growth temperature of the thermophilic bacterium according to the present invention needs to be 50 ° C. or higher. If the optimal growth temperature of the thermophile is less than the lower limit, it becomes difficult to separate the growth stage of the transformant and the expression stage of the enzyme. Moreover, as the optimal growth temperature of the thermophilic bacterium, the growth stage of the transformant and the expression stage of the enzyme can be further distinguished, and the culture for growing the transformant is easier. In view of the above, it is preferably 55 to 87 ° C, more preferably 55 to 65 ° C.
 本発明において、「低温菌及び中温菌」とは、至適増殖温度が50℃以下である微生物である。また、前記低温菌とは、至適増殖温度が30℃未満である微生物を指し、前記中温菌とは、至適増殖温度が30~50℃である微生物を指す。このような低温菌及び中温菌としては、真正細菌、古細菌、真核生物が挙げられ、発現が容易である観点からは、宿主微生物として真性細菌を用い、下記の低温菌及び中温菌由来酵素として真正細菌由来酵素を発現させることが好ましいことから、真正細菌であることがより好ましい。 In the present invention, “thermophilic and mesophilic bacteria” are microorganisms having an optimum growth temperature of 50 ° C. or lower. The thermophilic bacterium refers to a microorganism having an optimal growth temperature of less than 30 ° C., and the mesophilic bacterium refers to a microorganism having an optimal growth temperature of 30 to 50 ° C. Examples of such a thermophilic bacterium and mesophilic bacterium include eubacteria, archaea, and eukaryotes. From the viewpoint of easy expression, an eubacteria is used as a host microorganism, and the following psychrophilic and mesophilic bacterium-derived enzymes are used: Since it is preferable to express an eubacteria-derived enzyme, eubacteria are more preferable.
 前記低温菌及び中温菌としての真正細菌としては、特に制限されないが、例えば、大腸菌(Escherichia coli、至適増殖温度:37℃)、枯草菌(Bacillus subtilis、至適増殖温度:30℃)、コリネバクテリウム・グルタミウム(Corynebacterium glutamicum、至適増殖温度:28℃)、ラクトコッカス・ラクチス(Lactococcus lactis、至適増殖温度:30℃)、クロストリジウム・アセトブチリクム(Clostridium acetobutylicum、至適増殖温度:37℃)、シュードモナス・メバロニ(Pseudomonas mevalonii、至適増殖温度:30℃)が挙げられる。前記低温菌及び中温菌としての古細菌としても、特に制限されないが、例えば、メタノサルキナ・マゼイ(Methanosarcina mazei、至適増殖温度:37℃)が挙げられる。また、前記低温菌及び中温菌としての真核生物としても、特に制限されないが、例えば、サッカロマイセス・セレビシエ(Saccharomyces cerevisiae、至適増殖温度:25℃)が挙げられる。これらの中でも、前記低温菌及び中温菌としては、その微生物由来の酵素の使用実績が多い傾向にある観点から、大腸菌、枯草菌、クロストリジウム・アセトブチリクム、サッカロマイセス・セレビシエが好ましく、大腸菌が特に好ましい。 The eubacteria as the thermophilic bacterium and the mesophilic bacterium are not particularly limited. Bacterial glutamium (Corynebacterium glutamicum, optimal growth temperature: 28 ° C), Lactococcus lactis (Lactococcus lactis, optimal growth temperature: 30 ° C), Clostridium acetobutylicum (Crostridium acetobutylicum, optimal temperature 37 ° C) Pseudomonas mevaloni (Pseudomonas mevalonii, optimal growth temperature: 30 ° C.). The archaea as the thermophilic bacterium and the mesophilic bacterium are not particularly limited, and examples thereof include Methanosarcina mazei (optimum growth temperature: 37 ° C.). Further, eukaryotes as the above-mentioned thermophilic bacteria and mesophilic bacteria are not particularly limited, and examples thereof include Saccharomyces cerevisiae (optimum growth temperature: 25 ° C.). Among these, as the above-mentioned thermophilic bacterium and mesophilic bacterium, Escherichia coli, Bacillus subtilis, Clostridium acetobutylicum, and Saccharomyces cerevisiae are preferable, and Escherichia coli is particularly preferable from the viewpoint that there is a tendency to use many enzymes derived from the microorganism.
 本発明に係る低温菌及び中温菌の至適増殖温度としては、50℃以下であり、かつ、低温菌及び中温菌由来酵素をコードするDNAを導入する宿主細胞として用いる好熱菌の増殖温度よりも10℃以上低いことが必要である。低温菌及び中温菌の至適増殖温度が前記上限を超えると、形質転換体の増殖段階と低温菌及び中温菌由来酵素の発現段階とを分けることが困難となる。また、前記低温菌及び中温菌の至適増殖温度としては、形質転換体の増殖段階と酵素の発現段階とをより区別することができ、かつ、酵素の発現量をより多くすることができる傾向にある観点から、25~45℃であることが好ましく、25~40℃であることがより好ましい。 The optimum growth temperature of the thermophilic bacterium and mesophilic bacterium according to the present invention is 50 ° C. or lower, and from the growth temperature of thermophilic bacterium used as a host cell into which DNA encoding the enzyme derived from the psychrophilic bacterium and mesophilic bacterium is introduced. Also, it must be 10 ° C. or more lower. If the optimum growth temperature of the thermophilic bacterium and the mesophilic bacterium exceeds the upper limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic bacteria and the mesophilic bacterium-derived enzyme. In addition, as the optimum growth temperature of the above-mentioned thermophilic bacterium and mesophilic bacterium, the growth stage of the transformant and the expression stage of the enzyme can be further distinguished, and the expression level of the enzyme can be increased. In view of the above, it is preferably 25 to 45 ° C, more preferably 25 to 40 ° C.
 上記の好熱菌、低温菌及び中温菌は、例えば、BGSC(Bacillus Genetic Stock Center)、ATCC(The American Type Culture Collection)、DSMZ(Deutsche Sammlung von Mikroorganismen und Zellkulturen(German Collection of Microorganisms and Cell Cultures))、NPMD(独立行政法人 製品評価技術基盤機構 特許生物寄託センター)等の公的な機関や、民間販売会社から入手することができる。 Additional thermophilic bacteria, cold bacteria and mesophilic bacteria, e.g., BGSC (Bacillus Genetic Stock Center), ATCC (The American Type Culture Collection), DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen (German Collection of Microorganisms and Cell Cultures)) It can be obtained from public institutions such as NPMD (National Institute of Technology and Evaluation, Patent Biological Depositary Center) and private sales companies.
 本発明に係る「低温菌及び中温菌由来酵素」は、前記低温菌及び前記中温菌からなる群から選択される少なくとも1種の微生物に由来する酵素である。このような酵素としては、特に限定されないが、例えば、大腸菌由来の糖代謝系酵素、解糖系酵素、非メバロン酸経路酵素、ブタノール発酵酵素、脂肪酸合成酵素;枯草菌由来の解糖系酵素、非メバロン酸経路酵素、ブタノール発酵酵素;コリネバクテリウム・グルタミウム由来のブタノール発酵酵素、シキミ酸経路酵素;ラクトコッカス・ラクチス由来のブタノール発酵酵素;クロストリジウム・アセトブチリクム由来のアセトン-ブタノール-エタノール発酵酵素;シュードモナス・メバロニ由来のメバロン酸経路酵素;メタノサルキナ・マゼイ由来のメバロン酸経路酵素;サッカロマイセス・セレビシエ由来の解糖系酵素、エタノール発酵酵素、メバロン酸経路酵素が挙げられる。 The "Pyrogen and mesophilic bacterium-derived enzyme" according to the present invention is an enzyme derived from at least one microorganism selected from the group consisting of the psychrophilic bacterium and the mesophilic bacterium. Examples of such enzymes include, but are not limited to, for example, sugar metabolism enzymes derived from E. coli, glycolytic enzymes, non-mevalonate pathway enzymes, butanol fermentation enzymes, fatty acid synthetases; glycolytic enzymes derived from Bacillus subtilis, Non-mevalonate pathway enzyme, butanol fermentation enzyme; Butanol fermentation enzyme derived from Corynebacterium glutamine, Shikimate pathway enzyme; Butanol fermentation enzyme derived from Lactococcus lactis; Acetone-butanol-ethanol fermentation enzyme derived from Clostridium acetobutylicum; Pseudomonas -Mevalonate pathway enzyme derived from mevaloni; mevalonate pathway enzyme derived from methanosarkina mazei; glycolytic enzyme derived from Saccharomyces cerevisiae, ethanol fermentation enzyme, and mevalonate pathway enzyme.
 前記大腸菌由来の糖代謝系酵素としては、β-ガラクトシダーゼ(lacZ)が好ましい。また、前記大腸菌、前記枯草菌又は前記サッカロマイセス・セレビシエ由来の解糖系酵素としては、ヘキソキナーゼ、グルコース-6-リン酸イソメラーゼ、ホスホフルクトキナーゼ-1、フルクトース1,6-ビスリン酸アルドラーゼ、トリオースリン酸イソメラーゼ、グリセルアルデヒド-3-リン酸デヒドロゲナーゼ、ホスホグリセリン酸キナーゼ、ホスホグリセリン酸ムターゼ、ホスホピルビン酸ヒドラターゼ、ピルビン酸キナーゼが好ましい。 As the sugar metabolism enzyme derived from E. coli, β-galactosidase (lacZ) is preferable. The glycolytic enzymes derived from the Escherichia coli, Bacillus subtilis, or Saccharomyces cerevisiae include hexokinase, glucose-6-phosphate isomerase, phosphofructokinase-1, fructose 1,6-bisphosphate aldolase, triose phosphate. Preferred are isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, phosphopyruvate hydratase, and pyruvate kinase.
 前記大腸菌又は前記枯草菌由来の非メバロン酸経路酵素としては、DOXPシンターゼ、DOXPレダクトイソメラーゼ、4-ジホスホシチジル-2-C-メチル-D-エリトリトールシンターゼ、4-ジホスホヂチジル-2-C-メチル-D-エリトリトールキナーゼ、2-C-メチル-D-エリトリトール-2,4-シクロ二リン酸シンターゼ、HMB-PPシンターゼ、HMB-PPレダクターゼ、イソペンテニル二リン酸イソメラーゼが好ましい。 Non-mevalonate pathway enzymes derived from the E. coli or Bacillus subtilis include DOXP synthase, DOXP reductoisomerase, 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, 4-diphosphoditidyl-2-C-methyl-D. -Erythritol kinase, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase, HMB-PP synthase, HMB-PP reductase, isopentenyl diphosphate isomerase are preferred.
 前記大腸菌由来のブタノール発酵酵素としては、ケトール酸レダクトイソメラーゼ、ジヒドロキシ酸デヒドラターゼが好ましく、前記枯草菌由来のブタノール発酵酵素としては、アセト乳酸合成酵素が好ましく、コリネバクテリウム・グルタミウム由来のブタノール発酵酵素としては、ケトール酸レダクトイソメラーゼ、ジヒドロキシ酸デヒドラターゼ、
アルコール脱水素酵素が好ましく、前記ラクトコッカス・ラクチス由来のブタノール発酵酵素としては、ケト酸デカルボキシラーゼが好ましい。
As the butanol-fermenting enzyme derived from E. coli, ketol acid reductoisomerase and dihydroxy acid dehydratase are preferable. As the butanol-fermenting enzyme derived from Bacillus subtilis, acetolactate synthase is preferable, butanol-fermenting enzyme derived from Corynebacterium glutamicum. As ketol acid reduct isomerase, dihydroxy acid dehydratase,
Alcohol dehydrogenase is preferred, and the butanol fermentation enzyme derived from Lactococcus lactis is preferably keto acid decarboxylase.
 前記大腸菌由来の脂肪酸合成酵素としては、アセチル-CoAカルボキシラーゼ、ACP-アセチルトランスフェラーゼ、ACP-マロニルトランスフェラーゼ、β-ケトアシル-ACPシンターゼ、β-ケトアシルACPレダクターゼ、3-ヒドロキシアシルACPデヒドラーゼ、エノイルACPレダクターゼが好ましい。 As the fatty acid synthase derived from E. coli, acetyl-CoA carboxylase, ACP-acetyltransferase, ACP-malonyltransferase, β-ketoacyl-ACP synthase, β-ketoacyl ACP reductase, 3-hydroxyacyl ACP dehydrase, and enoyl ACP reductase are preferable. .
 前記コリネバクテリウム・グルタミウム由来のシキミ酸経路酵素としては、7-ホスホ-2-デヒドロ-3-デオキシアラビノヘプトン酸アルドラーゼ、3-デヒドロキナ酸シンターゼ、3-デヒドロキナ酸デヒドラターゼ、シキミ酸デヒドロゲナーゼ、シキミ酸キナーゼ、3-ホスホシキミ酸1-カルボキシビニルトランスフェラーゼ、コリスミ酸シンターゼ、コリスミ酸ムターゼが好ましい。 Examples of the shikimate pathway enzyme derived from Corynebacterium glutamicum include 7-phospho-2-dehydro-3-deoxyarabinoheptonic acid aldolase, 3-dehydroquinic acid synthase, 3-dehydroquinic acid dehydratase, shikimate dehydrogenase, shikimate Kinase, 3-phosphoshikimate 1-carboxyvinyltransferase, chorismate synthase, chorismate mutase are preferred.
 前記クロストリジウム・アセトブチリクム由来のアセトン-ブタノール-エタノール発酵酵素としては、ピルビン酸シンターゼ、チオラーゼ、3-ヒドロキシブチリル-CoAデヒドロゲナーゼ、クロトニルCoAヒドラターゼ、ブチリルCoAデヒドロゲナーゼ、アセトアルデヒドデヒドロゲナーゼ、エタノールデヒドロゲナーゼ、ブチルアルデヒドデヒドロゲナーゼ、ブタノールデヒドロゲナーゼ、アセト酢酸デカルボキシラーゼが好ましい。 Examples of the acetone-butanol-ethanol fermentation enzyme derived from Clostridium acetobutylicum include pyruvate synthase, thiolase, 3-hydroxybutyryl-CoA dehydrogenase, crotonyl CoA hydratase, butyryl CoA dehydrogenase, acetaldehyde dehydrogenase, ethanol dehydrogenase, butyraldehyde dehydrogenase, butanol Dehydrogenase and acetoacetate decarboxylase are preferred.
 前記シュードモナス・メバロニ由来のメバロン酸経路酵素としては、HMG-CoAレダクターゼが好ましく、メタノサルキナ・マゼイ又はサッカロマイセス・セレビシエ由来のメバロン酸経路酵素としては、アセチルCoAシンターゼ、アセチルCoA-アセチルトランスフェラーゼ、HMG-CoAシンターゼ、HMG-CoAレダクターゼ、メバロン酸キナーゼ、5-ホスホメバロン酸キナーゼ、ジホスホメバロン酸デカルボキシラーゼ、イソペンテニル二リン酸Δ-イソメラーゼが好ましい。前記サッカロマイセス・セレビシエ由来のエタノール発酵酵素としては、ピルビン酸デカルボキシラーゼ、アルコールデヒドロゲナーゼが好ましい。 As the mevalonate pathway enzyme derived from Pseudomonas mevaloni, HMG-CoA reductase is preferable, and as the mevalonate pathway enzyme derived from Methanosarcina mazei or Saccharomyces cerevisiae, acetyl CoA synthase, acetyl CoA-acetyltransferase, HMG-CoA synthase HMG-CoA reductase, mevalonate kinase, 5-phosphomevalonate kinase, diphosphomevalonate decarboxylase, isopentenyl diphosphate Δ-isomerase are preferred. As the ethanol fermentation enzyme derived from Saccharomyces cerevisiae, pyruvate decarboxylase and alcohol dehydrogenase are preferable.
 本発明に係る低温菌及び中温菌由来酵素としては、上記のうちの1種を単独で発現させても2種以上を組み合わせて発現させてもよい。これらの中でも、前記低温菌及び中温菌由来酵素としては、使用実績が多い傾向にある観点から、β-ガラクトシダーゼ、ピルビン酸デカルボキシラーゼ、アルコールデヒドロゲナーゼが好ましく、β-ガラクトシダーゼが特に好ましい。 As the enzymes derived from thermophilic bacteria and mesophilic bacteria according to the present invention, one of the above may be expressed alone, or two or more of them may be expressed in combination. Among these, as the enzyme derived from the psychrotrophic bacterium and mesophilic bacterium, β-galactosidase, pyruvate decarboxylase, and alcohol dehydrogenase are preferable, and β-galactosidase is particularly preferable from the viewpoint of tending to be used.
 上記の低温菌及び中温菌由来酵素をコードするDNAの配列情報は、公的に利用可能なデータベース、例えば、DDBJ(DNA Data Bank of Japan)、GenBank、EMBL(European Molecular Biology Laboratory)において入手することができる。 DNA sequence information encoding the above-mentioned enzymes derived from thermophilic and mesophilic bacteria should be obtained from publicly available databases such as DDBJ (DNA Data Bank of Japan), GenBank, EMBL (European Molecular Biology Laboratory). Can do.
 本発明の製造方法に係る第1の工程は、前記好熱菌に、前記低温菌及び中温菌由来酵素をコードするDNAを導入して、形質転換体を得る工程である。前記形質転換体を得る方法としては、特に制限されず、公知の方法又は公知の方法に適宜改変を加えた条件を適宜採用することができる。例えば、目的の低温菌及び/又は中温菌から慣行法によって目的の低温菌及び中温菌由来酵素をコードするDNAを単離し、単離したDNAを含む自己複製が可能な発現ベクターを調製して前記好熱菌に導入することによって目的の形質転換体を得ることができる。また、単離したDNAを含む発現ベクターを前記高熱菌に導入し、接合伝達等によって該DNAを前記高熱菌のゲノムに組み込むことによっても目的の形質転換体を得ることができる。 The first step according to the production method of the present invention is a step of obtaining a transformant by introducing DNA encoding the enzyme derived from the thermophilic bacterium and the mesophilic bacterium into the thermophilic bacterium. The method for obtaining the transformant is not particularly limited, and a known method or conditions obtained by appropriately modifying the known method can be appropriately employed. For example, DNA encoding the target thermophilic bacteria and mesophilic bacteria-derived enzyme is isolated from the target thermophilic bacteria and / or mesophilic bacteria by conventional methods, and an expression vector capable of self-replication containing the isolated DNA is prepared. The target transformant can be obtained by introduction into a thermophilic bacterium. Moreover, the target transformant can also be obtained by introducing an expression vector containing the isolated DNA into the hyperthermic bacterium and integrating the DNA into the genome of the hyperthermic bacterium by conjugation transfer or the like.
 前記DNAの単離方法としては、例えば、目的の低温菌及び中温菌由来酵素の塩基配列に基づいて作製したプライマーを用いて、目的の低温菌及び/又は中温菌のゲノムDNAを鋳型としたPCRを実施し、増幅したDNA断片を適当なベクターと連結することによって所望のゲノムDNAを単離する方法;目的の低温菌及び/又は中温菌からゲノムDNA又はmRNAを抽出し、これを基に合成したcDNAを適当なベクターと連結してDNAライブラリー又はcDNAライブラリーを作製し、目的の低温菌及び中温菌由来酵素の塩基配列に基づいて作製したプローブを用いたハイブリダイゼーションによって前記ライブラリーから所望のゲノムDNA又はcDNAを単離する方法;人工的に化学合成する方法が挙げられる。 Examples of the DNA isolation method include PCR using primers prepared based on the base sequences of the target psychrotrophic and mesophilic bacterium-derived enzymes and the genomic DNA of the target psychrophilic and / or mesophilic bacterium as a template. To isolate the desired genomic DNA by ligating the amplified DNA fragment with an appropriate vector; extracting genomic DNA or mRNA from the target psychrotrophic and / or mesophilic bacterium and synthesizing based on this The prepared cDNA is ligated with an appropriate vector to prepare a DNA library or cDNA library, and desired from the library by hybridization using a probe prepared based on the base sequences of the target thermophilic and mesophilic bacteria. A method for isolating the genomic DNA or cDNA; and a method for artificial chemical synthesis.
 前記発現ベクターは、そのポリヌクレオチド配列がコードするタンパク質を発現可能な状態で含むベクターであり、前記好熱菌内で複製可能であることが好ましく、例えば、プラスミド、ファージ、コスミドを基本に構築することができる。前記発現ベクターの母体となるプラスミドは、発現ベクターを導入する好熱菌の種類や導入方法に応じて適宜選択することができ、具体的には、例えば、pNW33N(GenBank ID: AY237122.1)、pUB110(GenBank ID: M19465.1)、pSTK1(GenBank ID: D29989.1)、pTB19(GenBank ID: M63891.1)、Hirokazu Suzukiら、Appl Environ Microbiol.、2012年10月、78(20)、p.7376‐7383に記載のpGAM46プラスミド等のプラスミド及びその誘導体が挙げられる。 The expression vector is a vector containing a protein encoded by the polynucleotide sequence in an expressible state, and is preferably replicable in the thermophilic bacterium. For example, the expression vector is constructed based on a plasmid, phage, or cosmid. be able to. The plasmid serving as the parent of the expression vector can be appropriately selected according to the type of thermophile into which the expression vector is introduced and the method of introduction. Specifically, for example, pNW33N (GenBank ID: AY237122.1), pUB110 (GenBank ID: M19465.1), pSTK1 (GenBank ID: D29989.1), pTB19 (GenBank ID: M63891.1), Hirokazu Suzuki et al., Appl Environ Microb. October 2012, 78 (20), p. Examples thereof include plasmids such as the pGAM46 plasmid described in 7376-7383 and derivatives thereof.
 前記発現ベクターとしては、前記低温菌及び中温菌由来酵素をコードするDNAの他に、これを実際に前記好熱菌に導入して前記酵素を発現させるために、その発現を制御するポリヌクレオチド配列や形質転換体を選択するための遺伝子マーカー等をさらに含んでいることが好ましい。また、前記低温菌及び中温菌由来酵素を精製するための精製用タグ配列をさらに含んでいることが好ましく、前記低温菌及び中温菌由来酵素を好熱菌外に分泌させる場合には分泌シグナル配列をさらに含んでいることが好ましい。 As the expression vector, in addition to DNA encoding the enzyme derived from the thermophilic bacterium and the mesophilic bacterium, a polynucleotide sequence for controlling the expression in order to express the enzyme by actually introducing the enzyme into the thermophilic bacterium Or a genetic marker for selecting a transformant. Further, it preferably further comprises a purification tag sequence for purifying the enzyme derived from the thermophilic bacterium and the mesophilic bacterium, and in the case of secreting the enzyme derived from the psychrophilic and mesophilic bacterium outside the thermophilic bacterium, a secretory signal sequence. It is preferable that it is further included.
 前記発現を制御するポリヌクレオチド配列としては、例えば、プロモーター、ターミネーター、又はシグナルペプチドをコードするポリヌクレオチド配列が挙げられる。前記遺伝子マーカーとしては、形質転換体の選択方法に応じて適宜選択することができ、例えば、薬剤耐性をコードする遺伝子や栄養要求性を相補する遺伝子を利用することができる。 Examples of the polynucleotide sequence that controls the expression include a polynucleotide sequence encoding a promoter, a terminator, or a signal peptide. The gene marker can be appropriately selected according to the selection method of the transformant. For example, a gene encoding drug resistance or a gene complementary to auxotrophy can be used.
 前記プロモーターとしては、目的の低温菌及び中温菌由来酵素に応じて適宜選択することができ、例えば、Hirokazu Suzukiら、Appl Environ Microbiol.、2013年9月、79(17)、p.5151‐5158に記載されている、Geobacillus kaustophilusの、Pgk704(推定アミロース代謝遺伝子プロモーター)、Pgk1859(推定セルビオース代謝遺伝子プロモーター)、Pgk1894(ミオイノシトール代謝遺伝子プロモーター)、Pgk1899(ミオイノシトール代謝遺伝子プロモーター)、Pgk1907(推定L-アラビノース代謝遺伝子プロモーター)、Pgk2150(推定D-ガラクトース代謝遺伝子プロモーター)、PsigA(dnaG遺伝子、sigA遺伝子プロモーター);Paul P.Linら、Metab.Eng.、2014年7月、24、p.192‐199に記載されている、Geobacillus thermoglucosidasiusの、Pglk(ヘキソキナーゼ遺伝子プロモーター)、Ppgi(グルコース-6-リン酸イソメラーゼ遺伝子プロモーター)、PpfkA(ホスホフルクトキナーゼ-1遺伝子プロモーター)、Pgap(グリセルアルデヒド-3-リン酸デヒドロゲナーゼ遺伝子プロモーター)、Ppgk(ホスホグリセリン酸キナーゼ遺伝子プロモーター)、Pgpm(ホスホグリセリン酸ムターゼ遺伝子プロモーター)、Peno(ホスホピルビン酸ヒドラターゼ遺伝子プロモーター)、Pldh(乳酸脱水素酵素遺伝子プロモーター)、PglpD(グリセロール-リン酸脱水素酵素遺伝子プロモーター)やBacillus subtilisのP43が挙げられる。このようなプロモーターは、一般に、前記低温菌及び中温菌由来酵素をコードするDNAの上流に位置させる。 The promoter can be appropriately selected according to the target psychrophilic and mesophilic bacterium-derived enzymes. For example, Hirokazu Suzuki et al., Appl Environ Microbiol. September 2013, 79 (17), p. 5151-5158, Geobacillus kaustophilus, Pgk704 (putative amylose metabolic gene promoter), Pgk1859 (putative serbiose metabolic gene promoter), Pgk1894 (myoinositol metabolic gene promoter), Pgk1899 (myoinositol metabolic gene promoter), Pgk1907 (Putative L-arabinose metabolic gene promoter), Pgk2150 (putative D-galactose metabolic gene promoter), PsigA (dnaG gene, sigA gene promoter); Lin et al., Metab. Eng. July 2014, 24, p. 192-199, Geobacillus thermoglucosidasis, Pglk (hexokinase gene promoter), Ppgi (glucose-6-phosphate isomerase gene promoter), PpfkA (phosphofructokinase-1 gene promoter), Pgap (glyceraldehyde) -3-phosphate dehydrogenase gene promoter), Ppgk (phosphoglycerate kinase gene promoter), Pgpm (phosphoglycerate mutase gene promoter), Peno (phosphopyruvate hydratase gene promoter), Pldh (lactate dehydrogenase gene promoter), PglpD (glycerol-phosphate dehydrogenase gene promoter) and Bacillus subtili Like P43 of. Such a promoter is generally located upstream of the DNA encoding the enzymes derived from the psychrotrophic and mesophilic bacterium.
 本発明においては、前記発現ベクターにおいて、前記低温菌及び中温菌由来酵素をコードするDNAがプロモーターに作動可能に連結していることが好ましく、また、前記発現ベクターが導入される好熱菌と、前記プロモーターの由来する微生物とが近縁にあることが好ましい。例えば、前記発現ベクターが導入される好熱菌がゲオバチルス属である場合、前記プロモーターとしては、グラム陽性の真正細菌由来のプロモーターであることが好ましく、ゲオバチルス属に含まれる真正細菌由来のプロモーター及びバチルス属に含まれる枯草菌由来のプロモーターからなる群から選択される少なくとも1種のプロモーターであることがより好ましい。 In the present invention, in the expression vector, it is preferable that the DNA encoding the enzyme derived from the psychrotrophic and mesophilic bacterium is operably linked to a promoter, and the thermophilic bacterium into which the expression vector is introduced; It is preferable that the microorganism from which the promoter is derived is closely related. For example, when the thermophilic bacterium into which the expression vector is introduced is of the genus Geobacillus, the promoter is preferably a promoter derived from a Gram-positive eubacteria, and a promoter derived from an eubacteria included in the genus Geobacillus and Bacillus More preferably, it is at least one promoter selected from the group consisting of promoters derived from Bacillus subtilis included in the genus.
 前記発現ベクターの作製方法は、特に制限されず、公知の方法、又は公知の方法に適宜修飾、改変を加えた方法を適宜採用することができる。例えば、前記プロモーターと前記低温菌及び中温菌由来酵素をコードするDNAと必要に応じて前記ターミネーター等とを連結して発現カセットを作製し、これをベクターに導入することで前記発現ベクターを得ることができれる。また、前記発現ベクターを作製するための酵素や条件についても特に限定されず、市販のものを適宜選択して用いることができる。 The production method of the expression vector is not particularly limited, and a known method or a method obtained by appropriately modifying or modifying the known method can be appropriately employed. For example, the expression vector is obtained by ligating the promoter, the DNA encoding the enzyme derived from the psychrotrophic bacterium and the mesophilic bacterium, and the terminator, if necessary, into the expression cassette, and introducing the expression cassette into the vector. I can do it. Moreover, the enzyme and conditions for producing the expression vector are not particularly limited, and commercially available products can be appropriately selected and used.
 前記好熱菌に前記発現ベクターを導入する形質転換方法としては、特に制限されず、公知の方法を適宜採用することができ、例えば、マイクロインジェクション法、エレクトロポレーション法、ポリエチレングリコール法、パーティクルガン法、プロトプラスト融合法、接合伝達法、リン酸カルシウム法を用いることができる。また、前記発現ベクターが導入される好熱菌としては、必要に応じて、特定の機能が欠損するように既に形質転換されたものや変異体であってもよい。 The transformation method for introducing the expression vector into the thermophilic bacterium is not particularly limited, and a known method can be appropriately employed. For example, a microinjection method, an electroporation method, a polyethylene glycol method, a particle gun Method, protoplast fusion method, junction transfer method, and calcium phosphate method can be used. In addition, the thermophilic bacterium into which the expression vector is introduced may be, if necessary, one that has already been transformed so as to lack a specific function or a mutant.
 本発明に係る第2の工程は、50℃以上の培養温度で前記形質転換体を培養して増殖させる工程である。第2の工程の培養温度が前記下限未満であると、形質転換体の増殖段階と低温菌及び中温菌由来酵素の発現段階とを分けることが困難となる。また、第2の工程の培養温度としては、形質転換体の増殖段階と酵素の発現段階とをより区別することができ、かつ、形質転換体を増殖させるための培養がより容易であるという観点から、55~87℃であることが好ましく、55~65℃であることがより好ましい。 The second step according to the present invention is a step in which the transformant is cultured and grown at a culture temperature of 50 ° C. or higher. If the culture temperature in the second step is lower than the lower limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic and mesophilic bacterium-derived enzymes. Further, as the culture temperature in the second step, it is possible to further distinguish between the growth stage of the transformant and the expression stage of the enzyme, and the viewpoint that the culture for growing the transformant is easier. Therefore, the temperature is preferably 55 to 87 ° C, more preferably 55 to 65 ° C.
 本発明に係る第3の工程は、第2の工程の後、培養温度を、50℃以下かつ第2の工程の培養温度よりも10℃以上低い温度に変えて低温菌及び中温菌由来酵素を発現させる工程である。第3の工程の培養温度が前記上限を超えると、形質転換体の増殖段階と低温菌及び中温菌由来酵素の発現段階とを分けることが困難となる。また、第3の工程の培養温度としては、形質転換体の増殖段階と酵素の発現段階とをより区別することができ、かつ、形質転換体の死滅を抑制する観点から、25~45℃であることが好ましく、30~45℃であることがより好ましく、40~45℃であることが更に好ましい。なお、本発明において、第3の工程の培養温度は、発現させる酵素が由来する前記低温菌及び中温菌の至適増殖温度と一致することは必ずしも必要ではなく、本発明の構成において第3の工程の培養温度が上記温度範囲内にあることで低温菌及び中温菌由来酵素を十分に発現させることができる。 In the third step according to the present invention, after the second step, the culture temperature is changed to a temperature lower than 50 ° C. and lower than the culture temperature of the second step by 10 ° C. It is a process of making it express. When the culture temperature in the third step exceeds the above upper limit, it becomes difficult to separate the growth stage of the transformant from the expression stage of the psychrophilic and mesophilic bacterium-derived enzymes. In addition, the culture temperature in the third step is 25 to 45 ° C. from the viewpoint of further distinguishing between the growth stage of the transformant and the expression stage of the enzyme and suppressing the killing of the transformant. It is preferably 30 to 45 ° C, more preferably 40 to 45 ° C. In the present invention, the culture temperature in the third step is not necessarily required to coincide with the optimum growth temperature of the above-mentioned thermophilic bacterium and mesophilic bacterium from which the enzyme to be expressed is derived. Enzymes derived from psychrophilic bacteria and mesophilic bacteria can be sufficiently expressed when the culture temperature in the step is within the above temperature range.
 また、本発明においては、前記形質転換体が対数増殖期にあるとき、より具体的には前記形質転換体を培養する培養液のOD600が1以下、さらに好ましくは0.1~0.9であるときに、培養温度を、第2の工程の培養温度から第3の工程の培養温度に変えることが好ましい。培養温度を変えるときのOD600が前記下限未満の場合には、形質転換体の増殖が十分ではないために酵素の発現量が少なくなる傾向にあり、他方、前記上限を超える場合には、酵素を発現させることが困難となる傾向にある。なお、本発明において、OD600値とは、形質転換体を培養している培養液(培地、微生物等、培養系に含まれる全成分を含む)の600nmにおける吸光度のことを指す。 In the present invention, when the transformant is in the logarithmic growth phase, more specifically, the OD 600 of the culture medium for culturing the transformant is 1 or less, more preferably 0.1 to 0.9. In this case, it is preferable to change the culture temperature from the culture temperature in the second step to the culture temperature in the third step. If the OD 600 when changing the culture temperature is less than the lower limit, the amount of expression of the enzyme tends to decrease because of insufficient growth of the transformant. On the other hand, if the OD 600 exceeds the upper limit, Tends to be difficult to express. In the present invention, the OD 600 value refers to the absorbance at 600 nm of a culture solution (including all components contained in the culture system such as culture medium and microorganisms) in which the transformant is cultured.
 また、本発明において、培養温度を第2の工程の温度から第3の工程の温度に変えた後の培養時間、すなわち、第3の工程の培養時間としては、宿主微生物である好熱菌の種類や培養条件にもよるが、例えば、前記好熱菌としてゲオバチルス属(より好ましくはゲオバチルス・サーモグルコシダシウス)を用いた場合には、1~48時間であることが好ましく、3~48時間であることがより好ましく、3~24時間であることが更に好ましく、3~15時間であることが特に好ましい。温度変更後の培養時間が前記下限未満の場合には、酵素の発現量が少なくなる傾向にあり、他方、前記上限を超える場合には、発現速度が低下して酵素の発現量が安定しなくなる傾向にある。 Further, in the present invention, the culture time after changing the culture temperature from the temperature of the second step to the temperature of the third step, that is, the culture time of the third step is that of the thermophile that is the host microorganism. Depending on the type and culture conditions, for example, when Geobacillus genus (more preferably, Geobacillus thermoglucosidashius) is used as the thermophilic bacterium, it is preferably 1 to 48 hours, and preferably 3 to 48 hours. More preferably, it is 3 to 24 hours, more preferably 3 to 15 hours. When the incubation time after the temperature change is less than the lower limit, the expression level of the enzyme tends to decrease. On the other hand, when the upper limit is exceeded, the expression rate decreases and the expression level of the enzyme becomes unstable. There is a tendency.
 前記第2の工程及び第3の工程において、形質転換体を培養するその他の条件(培地の組成、培地のpH、ガス(酸素、二酸化炭素等)濃度等)としては、特に制限されず、宿主微生物である好熱菌の種類に応じて、公知の培養条件、又は公知の培養条件に適宜修飾、改変を加えた条件から選択することができる。 In the second step and the third step, other conditions for culturing the transformant (medium composition, medium pH, gas (oxygen, carbon dioxide, etc.) concentration, etc.) are not particularly limited, and the host Depending on the type of thermophile that is a microorganism, it can be selected from known culture conditions or conditions obtained by appropriately modifying or modifying known culture conditions.
 本発明の製造方法により、前記第3の工程において、前記好熱菌を用いた形質転換体の増殖を抑制しつつ、目的の低温菌及び中温菌由来酵素を優先的に発現させることができる。例えば、前記発現ベクターとして分泌シグナル配列を含むベクターを用いた場合には、第2の工程後に培地を交換し、第3の工程で低温菌及び中温菌由来酵素を発現させることにより、前記酵素を選択的に培地中に得ることができるため、この培地を粗酵素として酵素反応に用いることができる。また、分泌シグナル配列を含むベクターを用いなかった場合でも、得られる低温菌及び中温菌由来酵素の最適温度付近では、宿主微生物である好熱菌由来の酵素の活性が抑制されるため、形質転換体を含む培養液をそのまま粗酵素として酵素反応に用いることができる。さらに前記酵素としては、形質転換体の培養終了後、形質転換体を遠心分離や濾過等によって回収し、細胞を破砕して得られる液を粗酵素として用いることもできる。また、これらの粗酵素を、限外濾過法等によって濃縮し、防腐剤等を加えて濃縮酵素とすることもできる。また、前記粗酵素又は前記濃縮酵素を、例えば、塩析法、有機溶媒沈殿法、膜分離法、クロマト分離法を単独で又は2種以上を組み合わせて用いることによって精製してもよい。さらに、前記発現ベクターとして精製用タグ配列を含むベクターを用いた場合には、精製用タグを付加した酵素をタグ付きタンパクの精製用カラムを用いて精製してもよい。 According to the production method of the present invention, in the third step, the target psychrophilic and mesophilic bacterium-derived enzymes can be preferentially expressed while suppressing the growth of transformants using the thermophilic bacterium. For example, when a vector containing a secretory signal sequence is used as the expression vector, the medium is changed after the second step, and the enzyme derived from the psychrophilic and mesophilic bacterium is expressed in the third step. Since it can be selectively obtained in a medium, this medium can be used as a crude enzyme in an enzyme reaction. Even when a vector containing a secretory signal sequence is not used, the activity of an enzyme derived from a thermophilic bacterium as a host microorganism is suppressed in the vicinity of the optimum temperature of the obtained psychrotrophic and mesophilic bacterium-derived enzymes. The culture solution containing the body can be used as it is in the enzyme reaction as a crude enzyme. Furthermore, as the enzyme, after completion of the culture of the transformant, a solution obtained by recovering the transformant by centrifugation or filtration and disrupting the cells can be used as the crude enzyme. Further, these crude enzymes can be concentrated by an ultrafiltration method or the like, and a preservative or the like can be added to obtain a concentrated enzyme. The crude enzyme or the concentrated enzyme may be purified by using, for example, a salting-out method, an organic solvent precipitation method, a membrane separation method, or a chromatographic separation method alone or in combination of two or more. Furthermore, when a vector containing a purification tag sequence is used as the expression vector, the enzyme to which the purification tag is added may be purified using a column for purification of the tagged protein.
 本発明の製造方法によって得られた低温菌及び中温菌由来酵素は、前記酵素の種類に応じて、様々な酵素反応に利用することができる。前記酵素反応としては、特に制限されないが、前記酵素と、その基質と、必要に応じて前記酵素の補酵素とを接触させて反応せしめる方法が挙げられる。このような酵素反応における各成分の濃度、溶媒の種類、温度条件、反応温度等については、前記低温菌及び中温菌由来酵素の種類に応じて適宜調整することができる。 The enzymes derived from psychrophilic and mesophilic bacteria obtained by the production method of the present invention can be used for various enzyme reactions depending on the kind of the enzyme. Although it does not restrict | limit especially as said enzyme reaction, The method of contacting the said enzyme, its substrate, and the coenzyme of the said enzyme as needed is mentioned. About the density | concentration of each component in such an enzyme reaction, the kind of solvent, temperature conditions, reaction temperature, etc., it can adjust suitably according to the kind of said thermophilic bacteria and mesophilic bacteria origin enzyme.
 以下、実施例に基づいて本発明をより具体的に説明するが、本発明は以下の実施例に限定されるものではない。 Hereinafter, the present invention will be described more specifically based on examples, but the present invention is not limited to the following examples.
 (実施例1)
 <DNA(lacZ)の単離>
 先ず、BL21(DE3)(メルク社)から、DNeasy Blood&Tissue Kit(Qiagen社)を用いてゲノムを抽出した。抽出したゲノムを鋳型として、HM48プライマー(配列番号:1に記載のヌクレオチド配列)、HM49プライマー(配列番号:2に記載のヌクレオチド配列)及びPCR酵素(KOD Fx Neo、東洋紡社)を用いて大腸菌β-ガラクトシダーゼをコードする配列(lacZ、配列番号:3に記載のヌクレオチド配列、GeneBank ID:CP001509.3(335840~332766))を増幅させた。増幅させたPCR産物はQIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製し、精製したPCR産物とpET28a+(メルク社)とを、それぞれ、NcoI(タカラバイオ社)及びNotI(タカラバイオ社)で切断し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。
Example 1
<Isolation of DNA (lacZ)>
First, genomes were extracted from BL21 (DE3) (Merck) using DNeasy Blood & Tissue Kit (Qiagen). Using the extracted genome as a template, Escherichia coli β using HM48 primer (nucleotide sequence described in SEQ ID NO: 1), HM49 primer (nucleotide sequence described in SEQ ID NO: 2) and PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) A sequence encoding galactosidase (lacZ, nucleotide sequence set forth in SEQ ID NO: 3, GeneBank ID: CP001509.3 (335840-332766)) was amplified. The amplified PCR product was purified using QIAquick Spin Gel Extraction Kit (Qiagen), and the purified PCR product and pET28a + (Merck) were respectively obtained with NcoI (Takara Bio) and NotI (Takara Bio). It cut | disconnected and refine | purified using QIAquick Spin Gel Extraction Kit (Qiagen).
 次いで、切断・精製後のPCR産物(68ng)及びpET28a+(233ng)をDNA Ligation Kit(Mighty Mix、タカラバイオ社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(25μg/mlカナマイシン)にて形質転換体を選抜し、3mlのLB培地(25μg/mlカナマイシン)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いてlacZを含むpESG23プラスミドを抽出した。 Subsequently, the PCR product (68 ng) and pET28a + (233 ng) after cleavage and purification were ligated using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.) and introduced into 200 μl of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (25 μg / ml kanamycin), inoculated into 3 ml of LB medium (25 μg / ml kanamycin) and grown. The pESG23 plasmid containing lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 <発現ベクターの調製>
 先ず、pNW33Nプラスミド(配列番号:4に記載のヌクレオチド配列、Bacillus Genetic Stock Centerより入手)をHindIII(タカラバイオ社)で切断し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。また、Kenji Tsugeら、Nucleic Acids Res.、2003年11月、31(21)に記載の合成DNAオリゴマーVsfiKpn-1F及びVsfiKpn-1Rの各5’末端をリン酸化させたオリゴマー(VsfiKpn-1F(5’末端リン酸化)及びVsfiKpn-1R(5’末端リン酸化))を98℃で5分間加熱した後、室温で自然冷却してインサートを作製した。切断・精製後のpNW33Nと前記インサートとを混合し、DNA Ligation Kit(Mighty Mix、タカラバイオ社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(25μg/mlクロラムフェニコール)にて形質転換体を選抜し、3mlのLB培地(25μg/mlクロラムフェニコール)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いて、SfiI部位を含むpNW(SfiI)プラスミドを抽出した。
<Preparation of expression vector>
First, pNW33N plasmid (nucleotide sequence described in SEQ ID NO: 4, obtained from Bacillus Genetic Stock Center) was cleaved with HindIII (Takara Bio) and purified using QIAquick Spin Gel Extraction Kit (Qiagen). Also, Kenji Tsuge et al., Nucleic Acids Res. November 2003, 31 (21), the oligomers (VsfiKpn-1F (5 ′ terminal phosphorylation) and VsfiKpn-1R (5s terminal phosphorylation) phosphorylated at each 5 ′ end of the synthetic DNA oligomers VsfiKpn-1F and VsfiKpn-1R ( 5 ′ terminal phosphorylation)) was heated at 98 ° C. for 5 minutes, and then naturally cooled at room temperature to produce an insert. The cleaved and purified pNW33N and the insert were mixed, ligated using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.), and introduced into 200 μl of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (25 μg / ml chloramphenicol), inoculated into 3 ml of LB medium (25 μg / ml chloramphenicol) and grown. The pNW (SfiI) plasmid containing the SfiI site was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 また、Paul P.Linら、Metabolic Engineering、2014年7月、24、p.192‐199に記載されているGeobacillus thermodenitrificansの乳酸脱水素酵素遺伝子プロモーター(ldh)を人工的に合成し、これを含むプラスミドを得た。このプラスミドを鋳型として、HM05bプライマー(配列番号:5に記載のヌクレオチド配列)、HM06‐minusプライマー(配列番号:6に記載のヌクレオチド配列)及びPCR酵素(KOD plus ver.2、東洋紡社)を用いてldhを増幅させた(PCR1)。 Also, Paul P.M. Lin et al., Metabolic Engineering, July 2014, 24, p. The lactobacillus thermodenitrificans lactate dehydrogenase gene promoter (ldh) described in 192-199 was artificially synthesized to obtain a plasmid containing the same. Using this plasmid as a template, HM05b primer (nucleotide sequence described in SEQ ID NO: 5), HM06-minus primer (nucleotide sequence described in SEQ ID NO: 6) and PCR enzyme (KOD plus ver. 2, Toyobo) were used. Ldh was amplified (PCR1).
 さらに、上記で得られたlacZを含むpESG23プラスミドを鋳型として、HM51プライマー(配列番号:7に記載のヌクレオチド配列)、HM52Hプライマー(His6タグを付加するプライマー、配列番号:8に記載のヌクレオチド配列)及びPCR酵素(KOD plus ver.2、東洋紡社)を用いてlacZを増幅させた(PCR2)。 Furthermore, using the pESG23 plasmid containing lacZ obtained above as a template, HM51 primer (nucleotide sequence described in SEQ ID NO: 7), HM52H primer (primer for adding His6 tag, nucleotide sequence described in SEQ ID NO: 8) And lacZ was amplified using PCR enzyme (KOD plus ver.2, Toyobo Co., Ltd.) (PCR2).
 PCR1及びPCR2で増幅させたPCR産物はそれぞれアガロースゲル電気泳動をして長さを確認した後、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。精製後のPCR1産物(100ng)及びPCR2産物(100ng)、HM05bプライマー、HM52Hプライマー、PCR酵素(KOD plus ver.2、東洋紡社)を用いて、Step1:98℃で10秒、Step2:60℃で30秒、Step3:68℃で4分、Step2からStep3への温度上昇速度:0.1℃/秒、35サイクルの条件でフュージョンPCRを行ってldh及びlacZを融合した発現カセットを作製した。 PCR products amplified by PCR1 and PCR2 were each subjected to agarose gel electrophoresis to confirm the length, and then purified using QIAquick Spin Gel Extraction Kit (Qiagen). Using purified PCR1 product (100 ng) and PCR2 product (100 ng), HM05b primer, HM52H primer, and PCR enzyme (KOD plus ver. 2, Toyobo), Step 1: 98 ° C. for 10 seconds, Step 2: 60 ° C. Fusion PCR was performed under the conditions of 30 seconds, Step 3: 68 ° C. for 4 minutes, and the temperature increase rate from Step 2 to Step 3: 0.1 ° C./second, 35 cycles to prepare an expression cassette in which ldh and lacZ were fused.
 上記で得られたpNW(SfiI)プラスミドをHindIIIで切断して前記発現カセットと混合し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した後、Gibson Assembly Master Mix(2x)(New England Biolabs社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(25μg/mlクロラムフェニコール)にて形質転換体を選抜し、3mlのLB培地(25μg/mlクロラムフェニコール)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いてldh及びlacZを含むpESG21Hプラスミド(配列番号:9に記載のヌクレオチド配列)を抽出した。 The pNW (SfiI) plasmid obtained above was cleaved with HindIII, mixed with the expression cassette, purified using QIAquick Spin Gel Extraction Kit (Qiagen), and then Gibson Assembly Master Mix (2x) And introduced into 200 μl of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (25 μg / ml chloramphenicol), inoculated into 3 ml of LB medium (25 μg / ml chloramphenicol) and grown. A pESG21H plasmid (nucleotide sequence described in SEQ ID NO: 9) containing ldh and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 <形質転換>
 宿主微生物として、Bacillus Genetic Stock Centerより取り寄せたゲオバシルス属の好熱菌(Geobacillus thermoglucosidasius DSM 2542、至適増殖温度:55℃)を用いた。好熱菌コンピテントセルの作製及び形質転換は、Mark P.Taylorら、Plasmid、2008年7月、60(1)、p.45-52に記載の方法に従って下記のように行った。
<Transformation>
As a host microorganism, a thermophilic bacterium belonging to the genus Geobacillus ordered from Bacillus Genetic Stock Center (Geobacillus thermoglocosidius DSM2542, optimum growth temperature: 55 ° C.) was used. Production and transformation of thermophilic bacteria competent cells is described in Mark P. et al. Taylor et al., Plasmid, July 2008, 60 (1), p. According to the method described in 45-52:
 (好熱菌コンピテントセルの作製)
 前記好熱菌をTGP培地プレート(トリプトン:17g/l、ソイトン:3g/l、KHPO:2.5g/l、NaCl:5g/l、ピルビン酸ナトリウム:4g/l、グリセロール:4ml/l、寒天(Agar):15g/l)に塗布して60℃で一晩培養後、得られたコロニーを1mlのTGP培地(トリプトン:17g/l、ソイトン:3g/l、KHPO:2.5g/l、NaCl:5g/l、ピルビン酸ナトリウム:4g/l、グリセロール:4ml/l)に植菌して60℃、180rpmで培養し、続いて50mlのTGP培地に植菌してOD600=1.6になるまで培養した後、氷上で10分間冷却した。その後、8000rpmで5分間遠心して集菌し、エレクトロポレーションバッファー(0.5Mソルビトール、0.5Mマンニトール、10%グリセロール)に菌を懸濁し、8000rpmで5分間遠心して集菌する作業を4回繰り返した。その後、1.5mlのエレクトロポレーションバッファーに懸濁し、60μlずつ分注して-80℃で保存した。
(Production of thermophilic bacteria competent cells)
The thermophile was added to a TGP medium plate (tryptone: 17 g / l, soyton: 3 g / l, K 2 HPO 4 : 2.5 g / l, NaCl: 5 g / l, sodium pyruvate: 4 g / l, glycerol: 4 ml / l l, Agar: 15 g / l) and after overnight culture at 60 ° C., the obtained colony was treated with 1 ml of TGP medium (tryptone: 17 g / l, soyton: 3 g / l, K 2 HPO 4 : 2.5 g / l, NaCl: 5 g / l, sodium pyruvate: 4 g / l, glycerol: 4 ml / l), cultured at 60 ° C. and 180 rpm, and then inoculated into 50 ml of TGP medium. After culturing until OD 600 = 1.6, the mixture was cooled on ice for 10 minutes. Thereafter, the cells were collected by centrifugation at 8000 rpm for 5 minutes, suspended in an electroporation buffer (0.5 M sorbitol, 0.5 M mannitol, 10% glycerol), and centrifuged at 8000 rpm for 5 minutes to collect the cells four times. Repeated. Thereafter, the suspension was suspended in 1.5 ml of electroporation buffer, dispensed in 60 μl aliquots, and stored at −80 ° C.
 (形質転換‐形質転換体の作製‐)
 上記で得られた好熱菌コンピテントセル(60μl)とpESG21Hプラスミド(500ng)とを混合し、0.1cmのキュベットに入れ、Gene Pulser Xcell(BioRad社)を用いて、2500V、10μF、600Ωの電気刺激を与えた。その後、1mlのTGP培地を添加して14mlポリプロピレンラウンドボトムチューブ(FALCON社)に移し、60℃で2時間振盪した後、TGP培地プレート(10μg/mlクロラムフェニコール)に塗布して60℃で一晩培養した。得られたコロニー(4コロニー)をそれぞれ3mlのLB培地に植菌し、60℃で一晩培養した後、等量の80%グリセロールを加えて形質転換体のグリセロールストックを作製し、-80℃で保存した。
(Transformation-Production of transformants-)
The thermophilic bacterium competent cell (60 μl) obtained above and the pESG21H plasmid (500 ng) were mixed, put into a 0.1 cm cuvette, and then using a Gene Pulser Xcell (BioRad), 2500 V, 10 μF, 600Ω. Electrical stimulation was given. Thereafter, 1 ml of TGP medium was added, transferred to a 14 ml polypropylene round bottom tube (FALCON), shaken at 60 ° C. for 2 hours, and then applied to a TGP medium plate (10 μg / ml chloramphenicol) at 60 ° C. Cultured overnight. The obtained colonies (4 colonies) were each inoculated into 3 ml of LB medium and cultured at 60 ° C. overnight, and then an equal amount of 80% glycerol was added to prepare a glycerol stock of the transformant. Saved with.
 <形質転換体の培養>
 先ず、上記で得られた形質転換体のグリセロールストックの一部をLB培地(25μg/mlクロラムフェニコール)に入れ、一晩培養した。次いで、500ml三角フラスコに120mlのLB培地(25μg/mlクロラムフェニコール)を入れ、一晩培養した培養液1mlを植菌した。培養機(BR-43FL、タイテック社)を用いて60℃、180rpmでOD600=0.785になるまで第2の工程の培養を行った。その後、200ml三角フラスコに培養液を30ml入れ、培養温度を42℃に変えて第3の工程の培養を行った。第3の工程の培養を開始してから(培養温度を42℃に変えてから)0、1.5、3、24時間培養後の培養液のOD600を計測して増殖曲線を得た。
<Culture of transformant>
First, a part of the glycerol stock of the transformant obtained above was placed in LB medium (25 μg / ml chloramphenicol) and cultured overnight. Next, 120 ml of LB medium (25 μg / ml chloramphenicol) was placed in a 500 ml Erlenmeyer flask and inoculated with 1 ml of an overnight culture. Using the incubator (BR-43FL, Taitec Co., Ltd.), the second step of culture was performed at 60 ° C. and 180 rpm until OD 600 = 0.785. Thereafter, 30 ml of the culture solution was placed in a 200 ml Erlenmeyer flask, and the culture temperature was changed to 42 ° C. to perform the third step of culture. After starting the culture in the third step (after changing the culture temperature to 42 ° C.), OD 600 of the culture solution after culturing for 0, 1.5, 3, 24 hours was measured to obtain a growth curve.
 <β‐ガラクトシダーゼ活性評価‐酵素反応‐>
 第3の工程の培養を開始してから(培養温度を変えてから)0、3、24時間培養後に、それぞれ、14mlポリプロピレンラウンドボトムチューブに3mlの培養液を採り、DMSO(ジメチルスルホキシド)に溶解した2% 5-ブロモ-4-クロロ-3-インドリル-β-D-ガラクトピラノシド(X-gal)を50μl添加し、42℃で1時間振盪しながらインキュベートし、β‐ガラクトシダーゼの活性を評価した。評価はインキュベート後の培養液の外観(色)を目視で観察し、以下の基準:
  0:橙色(青色が確認されない(X-galを添加しなかったものと同じ培地の色である)
  1:黄色(わずかに青色がかっているがX-galを添加しなかったものとほとんど変わらない)
  2:黄緑色(青色が確認される)
  3:緑色
  4:青色
に基づいておこなった。なお、評価の数値が大きいほど、酵素が多く発現していると判断できる。
<Evaluation of β-galactosidase activity-Enzyme reaction->
After culturing for the third step (after changing the culture temperature), after culturing for 0, 3, and 24 hours, take 3 ml of the culture solution in a 14 ml polypropylene round bottom tube and dissolve in DMSO (dimethyl sulfoxide). 50 μl of 2% 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) was added and incubated at 42 ° C. for 1 hour with shaking to determine the activity of β-galactosidase. evaluated. The evaluation was performed by visually observing the appearance (color) of the culture solution after incubation, and the following criteria:
0: Orange (no blue color is confirmed (the color of the medium is the same as that without X-gal))
1: Yellow (slightly blue but almost the same as when X-gal was not added)
2: Yellowish green (blue is confirmed)
3: Green 4: Performed based on blue. In addition, it can be judged that the enzyme is expressing more, so that the numerical value of evaluation is large.
 (実施例2)
 形質転換体の培養において、第3の工程の培養温度を37℃としたこと以外は実施例1と同様にして培養した。第3の工程の培養を開始してから(培養温度を37℃に変えてから)0、1.5、3、24時間培養後の培養液のOD600を計測して増殖曲線を得た。また、X-galを添加した後のインキュベート温度を37℃としたこと以外は実施例1と同様にしてβ‐ガラクトシダーゼ活性評価を実施した。
(Example 2)
In culturing the transformant, the culture was performed in the same manner as in Example 1 except that the culture temperature in the third step was 37 ° C. After starting the culture in the third step (after changing the culture temperature to 37 ° C.), OD 600 of the culture solution after culturing for 0, 1.5, 3, 24 hours was measured to obtain a growth curve. Further, β-galactosidase activity was evaluated in the same manner as in Example 1 except that the incubation temperature after adding X-gal was 37 ° C.
 (比較例1)
 形質転換体の培養において、第3の工程の培養温度を第2の工程に引き続き60℃のままとしたこと以外は実施例1と同様にして培養した。また、第2の工程の培養開始時間を-5時間、第3の工程の培養開始時間を0時間として、-3.5、-1、0、1.5、3、24時間培養後のOD600を計測して増殖曲線を得た。さらに、X-galを添加した後のインキュベート温度を60℃としたこと以外は実施例1と同様にしてβ‐ガラクトシダーゼ活性評価を実施した。
(Comparative Example 1)
In the culture of the transformant, the culture was performed in the same manner as in Example 1 except that the culture temperature in the third step was kept at 60 ° C. following the second step. Also, OD after culturing at −3.5, −1, 0, 1.5, 3, 24 hours, assuming that the culture start time of the second step is −5 hours and the culture start time of the third step is 0 hours. 600 is measured to obtain a growth curve. Further, β-galactosidase activity was evaluated in the same manner as in Example 1 except that the incubation temperature after addition of X-gal was 60 ° C.
 実施例1~2及び比較例1において得られた増殖曲線を図1に示す。また、β‐ガラクトシダーゼ活性の評価結果を表1に示す。さらに、比較例1の第3の工程の培養開始時(0時間培養後)の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を示す写真を図2Aに、実施例1~2及び比較例1の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を示す写真を図2Bに、実施例1~2及び比較例1の第3の工程の培養開始から24時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価を実施したときの外観を示す写真を図2Cに、それぞれ示す。 The growth curves obtained in Examples 1 and 2 and Comparative Example 1 are shown in FIG. The evaluation results of β-galactosidase activity are shown in Table 1. Furthermore, FIG. 2A is a photograph showing the appearance when the β-galactosidase activity evaluation is performed on the culture solution at the start of the culture in the third step of Comparative Example 1 (after 0 hour culture). FIG. 2B is a photograph showing the external appearance when β-galactosidase activity evaluation was performed on the culture solution after 3 hours of culture from the start of the culture in the third step of Example 1, and the third example of Examples 1-2 and Comparative Example 1 was used. The photographs showing the external appearance when the β-galactosidase activity evaluation is performed on the culture solution after 24 hours of cultivation from the start of the cultivation in the step are shown in FIG. 2C, respectively.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 (実施例3)
 <DNA(lacZ)の単離>
 実施例1と同様にして、lacZを含むpESG23プラスミドを得た。
(Example 3)
<Isolation of DNA (lacZ)>
In the same manner as in Example 1, a pESG23 plasmid containing lacZ was obtained.
 <発現ベクターの調製>
 先ず、Hirokazu Suzukiら、Appl Environ Microbiol.、2012年10月、78(20)、p.7376‐7383に記載のpGAM46プラスミドをHindIII(タカラバイオ社)で切断し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。また、前記合成DNAオリゴマーVsfiKpn-1F(5’末端リン酸化)及びVsfiKpn-1R(5’末端リン酸化))を98℃で5分間加熱した後、室温で自然冷却してインサートを作製した。切断・精製後のpGAM46と前記インサートとを混合し、DNA Ligation Kit(Mighty Mix、タカラバイオ社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(100μg/mlアンピシリン)にて形質転換体を選抜し、3mlのLB培地(100μg/mlアンピシリン)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いて、SfiI部位を含むpGAM46(SfiI)プラスミドを抽出した。
<Preparation of expression vector>
First, Hirokazu Suzuki et al., Appl Environ Microbiol. October 2012, 78 (20), p. The pGAM46 plasmid described in 7376-7383 was cleaved with HindIII (Takara Bio Inc.) and purified using QIAquick Spin Gel Extraction Kit (Qiagen Inc.). The synthetic DNA oligomers VsfiKpn-1F (5 ′ end phosphorylation) and VsfiKpn-1R (5 ′ end phosphorylation)) were heated at 98 ° C. for 5 minutes, and then naturally cooled at room temperature to produce an insert. The cut and purified pGAM46 and the insert were mixed, ligated using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.), and introduced into 200 μl of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (100 μg / ml ampicillin), inoculated into 3 ml of LB medium (100 μg / ml ampicillin) and grown. A pGAM46 (SfiI) plasmid containing the SfiI site was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 また、Geobacillus kaustophilus HTA426ゲノム由来の推定アミロース代謝遺伝子プロモーター(Pgk704プロモーター(Pgk704)、配列番号:10に記載のヌクレオチド配列)を含むプラスミドを鋳型として、HindIII-promoter-fwプライマー(配列番号:11に記載のヌクレオチド配列)、promoter‐rvプライマー(配列番号:12に記載のヌクレオチド配列)及びPCR酵素(KOD Fx Neo、東洋紡社)を用いてPgk704を増幅させた(PCR1)。 In addition, a HindIII-promoter-fw primer (described in SEQ ID NO: 11) using a plasmid containing a putative amylose metabolic gene promoter (Pgk704 promoter (Pgk704), nucleotide sequence described in SEQ ID NO: 10) derived from the Geobacillus kaustophilus HTA426 genome as a template. Pgk704 was amplified using a promoter-rv primer (nucleotide sequence described in SEQ ID NO: 12) and a PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) (PCR1).
 さらに、上記で得られたlacZを含むpESG23プラスミドを鋳型として、promoter-bGalE-fwプライマー(配列番号:13に記載のヌクレオチド配列)、HindIII-H6-bGalE-rvプライマー(配列番号:14に記載のヌクレオチド配列)及びPCR酵素(KOD Fx Neo、東洋紡社)を用いてlacZを増幅させた(PCR2)。 Furthermore, using the pESG23 plasmid containing lacZ obtained above as a template, promoter-bGalE-fw primer (nucleotide sequence described in SEQ ID NO: 13), HindIII-H6-bGalE-rv primer (described in SEQ ID NO: 14) LacZ was amplified using (nucleotide sequence) and PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.) (PCR2).
 PCR1及びPCR2で増幅させたPCR産物はそれぞれアガロースゲル電気泳動をして長さを確認した後、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。精製後のPCR1産物及びPCR2産物、HindIII-promoter-fwプライマー、HindIII-H6-bGalE-rvプライマー、PCR酵素(KOD Fx Neo、東洋紡社)を用いてフュージョンPCRを行い、Pgk704及びlacZを融合した発現カセットを作製した。 PCR products amplified by PCR1 and PCR2 were each subjected to agarose gel electrophoresis to confirm the length, and then purified using QIAquick Spin Gel Extraction Kit (Qiagen). The fusion PCR was performed using PCR1 product and PCR2 product after purification, HindIII-promoter-fw primer, HindIII-H6-bGalE-rv primer, PCR enzyme (KOD Fx Neo, Toyobo Co., Ltd.), and Pgk704 and lacZ were fused. A cassette was made.
 前記pNW(SfiI)プラスミドをHindIIIで切断してCIAP処理(Alkaline Phosphatase(Calf intestine)、タカラバイオ社)を施し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した後、HindIIIで処理して同様に精製した前記発現カセットと混合して、DNA Ligation Kit(Mighty Mix、タカラバイオ社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(34μg/mlクロラムフェニコール)にて形質転換体を選抜し、3mlのLB培地(34μg/mlクロラムフェニコール)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いてPgk704及びlacZを含むpESG28プラスミドを抽出した。 The pNW (SfiI) plasmid was cleaved with HindIII, treated with CIAP (Alkaline Phosphatase (Calf intestine), Takara Bio), purified with QIAquick Spin Gel Extraction Kit (Qiagen), and purified with H in III. It mixed with the said expression cassette refine | purified similarly, it connected using DNA Ligation Kit (Mighty Mix, Takara Bio Inc.), and introduce | transduced into 200 microliters E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (34 μg / ml chloramphenicol), inoculated into 3 ml of LB medium (34 μg / ml chloramphenicol) and grown. A pESG28 plasmid containing Pgk704 and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 次いで、得られたpESG28プラスミドを鋳型として、HM58プライマー(配列番号:15に記載のヌクレオチド配列)、HM60プライマー(配列番号:16に記載のヌクレオチド配列)及びPCR酵素(KOD plus Ver.2、東洋紡社)を用いてPgk704及びlacZが連結された配列を増幅させた(PCR3)。 Next, using the obtained pESG28 plasmid as a template, HM58 primer (nucleotide sequence described in SEQ ID NO: 15), HM60 primer (nucleotide sequence described in SEQ ID NO: 16) and PCR enzyme (KOD plus Ver. 2, Toyobo Co., Ltd.) ) Was used to amplify the sequence in which Pgk704 and lacZ were linked (PCR3).
 PCR3で増幅させたPCR3産物はアガロースゲル電気泳動をして長さを確認した後、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した。また、上記で得られたpGAM46(SfiI)プラスミドをHindIIIで切断し、QIAquick Spin Gel Extraction Kit(Qiagen社)を用いて精製した後、同様に精製したPCR3産物と混合して、In-Fusion HD Cloning Kit(タカラバイオ社)を用いて連結し、200μlの大腸菌JM109ケミカルコンピテントセルに導入した。LB培地プレート(100μg/mlアンピシリン)にて形質転換体を選抜し、3mlのLB培地(100μg/mlアンピシリン)に植菌して増殖させた。増殖させた形質転換体からQIAprep spin miniprep kit(Qiagen社)を用いてPgk704及びlacZを含むpESG32プラスミドを抽出した。 The PCR3 product amplified by PCR3 was subjected to agarose gel electrophoresis to confirm the length, and then purified using a QIAquick Spin Gel Extraction Kit (Qiagen). In addition, the pGAM46 (SfiI) plasmid obtained above was cleaved with HindIII, purified using QIAquick Spin Gel Extraction Kit (Qiagen), mixed with the PCR3 product purified in the same manner, and In-Fusion HD Cloning. The cells were ligated using Kit (Takara Bio Inc.) and introduced into 200 μl of E. coli JM109 chemical competent cell. Transformants were selected on an LB medium plate (100 μg / ml ampicillin), inoculated into 3 ml of LB medium (100 μg / ml ampicillin) and grown. A pESG32 plasmid containing Pgk704 and lacZ was extracted from the grown transformant using QIAprep spin miniprep kit (Qiagen).
 <形質転換>
 宿主微生物として、Suzuki Hirokazuら、Appl Environ Microbiol.、2015年1月、81(1)、p.149-158に記載のゲオバシルス属の好熱菌(Geobacillus kaustophilus MK242、至適増殖温度:55℃)を用いた。Geobacillus kaustophilus MK242は、鳥取大学大学院工学研究科鈴木宏和博士より入手した。先ず、Suzuki Hirokazuら、J Microbiol Biotechnol.、2012年9月、22(9)、p.1279-1287に記載の方法に従って大腸菌にpESG32プラスミドを導入した。
<Transformation>
As host microorganisms, Suzuki Hirokazu et al., Appl Environ Microbiol. January 2015, 81 (1), p. The thermophile of the genus Geobacillus described in 149-158 (Geobacillus kaustophilus MK242, optimal growth temperature: 55 ° C.) was used. Geobacillus kaustophilus MK242 was obtained from Dr. Hirokazu Suzuki, Graduate School of Engineering, Tottori University. First, Suzuki Hirokazu et al., J Microbiol Biotechnol. September 2012, 22 (9), p. The pESG32 plasmid was introduced into E. coli according to the method described in 1279-1287.
 すなわち、Suzuki Hirokazuら、J Microbiol Biotechnol.、2012年9月、22(9)、p.1279-1287に記載の大腸菌BR408をLB培地で培養した後、超純水に菌を懸濁・遠心して集菌する作業を3回繰り返した。その後、10%グリセロールに懸濁して大腸菌コンピテントセルを得た。次いで、得られた大腸菌コンピテントセル(60μl)とpESG32プラスミドとを混合し、0.1cmのキュベットに入れ、Gene Pulser Xcell(BioRad社)を用いて、1800V、25μF、200Ωの電気刺激を与えた。その後、1mlのLB培地を添加して37℃で1時間振盪した後、LB培地プレート(100μg/mlアンピシリン、34μg/mlクロラムフェニコール、25μg/mlカナマイシン)に塗布して37℃で一晩培養し、pESG32プラスミドが導入された大腸菌BR408(pESG32)のコロニーを得た。 That is, Suzuki Hirokazu et al., J Microbiol Biotechnol. September 2012, 22 (9), p. After culturing Escherichia coli BR408 described in 1279-1287 in LB medium, the operation of suspending and centrifuging the cells in ultrapure water and collecting the cells was repeated three times. Thereafter, the cells were suspended in 10% glycerol to obtain E. coli competent cells. Next, the obtained Escherichia coli competent cell (60 μl) and the pESG32 plasmid were mixed, put into a 0.1 cm cuvette, and 1800 V, 25 μF, and 200 Ω electrical stimulation were given using Gene Pulser Xcell (BioRad). . Thereafter, 1 ml of LB medium was added and shaken at 37 ° C. for 1 hour, and then applied to an LB medium plate (100 μg / ml ampicillin, 34 μg / ml chloramphenicol, 25 μg / ml kanamycin) overnight at 37 ° C. After culturing, colonies of E. coli BR408 (pESG32) into which the pESG32 plasmid was introduced were obtained.
 次いで、Hirokazu Suzukiら、Appl Environ Microbiol.、2012年10月、78(20)、p.7376‐7383に記載の方法に従って、接合伝達により、Geobacillus kaustophilus MK242にpESG32プラスミドを導入した。 Then, Hirokazu Suzuki et al., Appl Environ Microbiol. October 2012, 78 (20), p. The pESG32 plasmid was introduced into Geobacillus kaustophilus MK242 by conjugation transfer according to the method described in 7376-7383.
 すなわち、先ず、前記大腸菌BR408(pESG32)のコロニーをLB培地(100μg/mlアンピシリン、34μg/mlクロラムフェニコール、25μg/mlカナマイシン)で37℃において、Geobacillus kaustophilus MK242をLB培地(抗生物質不添加)で60℃において、それぞれ、OD600=0.6になるまで培養した。次いで、大腸菌BR408(pESG32)とGeobacillus kaustophilus MK242とを2:8(質量比)の割合で混合し、減圧濾過によりメンブレンフィルター(ポアサイズ:0.2μm、Omnipore、メルクミリポア社)に菌を吸着させ、これをLB寒天培地に乗せて37℃で4~6時間培養した。 That is, first, the colonies of the E. coli BR408 (pESG32) were transformed into LB medium (100 μg / ml ampicillin, 34 μg / ml chloramphenicol, 25 μg / ml kanamycin) at 37 ° C., and Geobacillus kaustophilus MK242 was added to LB medium (no antibiotics added). ) At 60 ° C. until OD 600 = 0.6. Next, E. coli BR408 (pESG32) and Geobacillus kaustophilus MK242 were mixed at a ratio of 2: 8 (mass ratio), and the bacteria were adsorbed on a membrane filter (pore size: 0.2 μm, Omnipore, Merck Millipore) by filtration under reduced pressure. This was placed on an LB agar medium and cultured at 37 ° C. for 4 to 6 hours.
 その後、これを最少培地(KSO:0.3g/l、NaHPO・12HO:2.5g/l、NHCl:1g/l、Casamino Acids(BD Bacto Casamino Acids、Vitamin Assay):1g/l、MgSO:0.4g/l、MnCl・4HO:3mg/l、CaCl・2HO:5mg/l、FeCl・6HO:7mg/l、Tris-HCl(pH 7.6):10mM、D-glucose:10g/l、Trace Element:0.10%vol/vol(Trace Element:ZnSO・7HO:400mg/l、HBO:10mg/l、CoCl・6HO:50mg/l、CuSO:200mg/l、NiCl・6HO:10mg/l、EDTA:250mg/l))プレートに移し、60℃で一晩培養して、pESG32プラスミド配列がゲノムに組み込まれたGeobacillus kaustophilus MK242(MK242(pESG32))のコロニーを得た。 Then, this was added to the minimum medium (K 2 SO 4 : 0.3 g / l, Na 2 HPO 4 · 12H 2 O: 2.5 g / l, NH 4 Cl: 1 g / l, Casamino Acids (BD Bacto Casano Acids, Vitamin Assay): 1 g / l, MgSO 4 : 0.4 g / l, MnCl 2 · 4H 2 O: 3 mg / l, CaCl 2 · 2H 2 O: 5 mg / l, FeCl 3 · 6H 2 O: 7 mg / l, Tris HCl (pH 7.6): 10 mM, D-glucose: 10 g / l, Trace Element: 0.10% vol / vol (Trace Element: ZnSO 4 .7H 2 O: 400 mg / l, H 3 BO 3 : 10 mg / L, CoCl 2 · 6H 2 O: 50 mg / l, CuSO 4 : 200 mg / l, NiCl 2 · 6H 2 O: 10mg / l, EDTA: 250mg / l)) were transferred to the plate, 60 and cultured overnight at ° C., colonies of Geobacillus kaustophilus MK242 which PESG32 plasmid sequences integrated into the genome (MK242 (pESG32)) Got.
 得られたMK242(pESG32)のコロニーを200mlのLB培地で培養し、培養液200μlを200mlのLB培地に植菌して培養する作業を4回繰り返した後、培養液1mlを遠心して得られた沈殿を超純水1mlに懸濁した。50μl又は250μlの懸濁液を5mlの選択最少培地1(前記最少培地に1μg/mlウラシル、50μg/ml 5-フルオロオロチン酸を添加した培地)で4~6時間培養した。その後、1μl又は100μlの培養液を選択最少培地2(前記最少培地に10μg/mlウラシル、50μg/ml 5-フルオロオロチン酸を添加した培地)のプレートに塗布し、60℃で約1日間培養してコロニーを得た。得られたコロニーを更に前記選択最少培地のプレート及びLB培地のプレートにそれぞれ塗布し、前記最少選択培地で増殖しなかったコロニーを選択してそれと対応するLB培地のコロニーからグリセロールストックを作製し、下記の形質転換体の培養及びβ‐ガラクトシダーゼ活性評価に用いた。前記最少選択培地で増殖しなかったコロニーは、MK242(pESG32)のうち、pGAM46由来の配列を含まないもの、すなわち、Pgk704及びlacZがゲノムに組み込まれたGeobacillus kaustophilus MK242(MK242(Pgk704/lacZ))である。 The obtained colony of MK242 (pESG32) was cultured in 200 ml of LB medium, and 200 μl of the culture solution was inoculated into 200 ml of LB medium and cultured four times, and then 1 ml of the culture solution was centrifuged. The precipitate was suspended in 1 ml of ultrapure water. 50 μl or 250 μl of suspension was cultured for 4-6 hours in 5 ml of selective minimal medium 1 (medium supplemented with 1 μg / ml uracil, 50 μg / ml 5-fluoroorotic acid to the minimal medium). Thereafter, 1 μl or 100 μl of the culture solution is applied to a plate of selective minimal medium 2 (medium supplemented with 10 μg / ml uracil, 50 μg / ml 5-fluoroorotic acid to the minimal medium), and cultured at 60 ° C. for about 1 day. To obtain a colony. The obtained colonies were further applied to the selective minimal medium plate and the LB medium plate, respectively, and the colonies that did not grow on the minimal selective medium were selected to produce glycerol stocks from the corresponding colonies of the LB medium, The following transformants were cultured and used for β-galactosidase activity evaluation. The colonies that did not grow on the minimal selection medium are those that do not contain pGAM46-derived sequences among MK242 (pESG32), that is, Geobacillus kaustophilus MK242 (MK242 (Pgk704 / lacZ)) in which Pgk704 and lacZ are integrated into the genome. It is.
 <形質転換体の培養>
 形質転換体として上記で得られたMK242(Pgk704/lacZ)を用い、第2の工程の培養をOD600=0.425になるまで行ったこと以外は実施例1と同様にして形質転換体の培養を行い、第3の工程の培養を開始してから(培養温度を42℃に変えてから)0、1.5、3、6、24、30時間培養後の培養液のOD600を計測して増殖曲線を得た。
<Culture of transformant>
Using MK242 (Pgk704 / lacZ) obtained above as a transformant, the transformant was treated in the same manner as in Example 1 except that the culture in the second step was performed until OD 600 = 0.425. After culturing and starting the culture in the third step (after changing the culture temperature to 42 ° C.), measure the OD 600 of the culture after 0, 1.5, 3, 6 , 24, 30 hours of culture. A growth curve was obtained.
 <β‐ガラクトシダーゼ活性評価‐酵素反応‐>
 第3の工程の培養を開始してから(培養温度を変えてから)0、3、6時間培養後の培養液をそれぞれ用いたこと以外は実施例1と同様にして、β‐ガラクトシダーゼ活性評価を実施した。また、X-galを添加した後のインキュベート時間を3時間としたものについても同様にβ‐ガラクトシダーゼ活性評価を実施した。
<Evaluation of β-galactosidase activity-Enzyme reaction->
Evaluation of β-galactosidase activity in the same manner as in Example 1 except that the culture solution after culturing for 0, 3, and 6 hours after starting the culture in the third step (after changing the culture temperature) was used. Carried out. In addition, β-galactosidase activity was evaluated in the same manner for those in which the incubation time after addition of X-gal was 3 hours.
 (実施例4)
 第3の工程の培養温度を37℃としたこと以外は実施例3と同様にして形質転換体の培養を行い、増殖曲線を得た。また、X-galを添加した後のインキュベート温度を37℃としたこと以外は実施例3と同様にして、β‐ガラクトシダーゼ活性評価を実施した。
(Example 4)
Transformants were cultured in the same manner as in Example 3 except that the culture temperature in the third step was 37 ° C., and a growth curve was obtained. In addition, β-galactosidase activity was evaluated in the same manner as in Example 3 except that the incubation temperature after adding X-gal was 37 ° C.
 (比較例2)
 形質転換体の培養において、第3の工程の培養温度を第2の工程に引き続き60℃のままとしたこと以外は実施例3と同様にして形質転換体の培養を行い、第2の工程の培養開始時間を-2.5時間、第3の工程の培養開始時間を0時間として、-2.5、-1、0、1.5、3、6、24、30時間培養後のOD600を計測して増殖曲線を得た。さらに、X-galを添加した後のインキュベート温度を60℃としたこと以外は実施例3と同様にして、β‐ガラクトシダーゼ活性評価を実施した。
(Comparative Example 2)
In the culture of the transformant, the transformant was cultured in the same manner as in Example 3 except that the culture temperature in the third step was kept at 60 ° C. following the second step. OD 600 after culturing at −2.5, −1, 0, 1.5, 3, 6, 24, and 30 hours, assuming that the culture start time is −2.5 hours and the culture start time of the third step is 0 hours. Was measured to obtain a growth curve. Furthermore, β-galactosidase activity was evaluated in the same manner as in Example 3 except that the incubation temperature after addition of X-gal was 60 ° C.
 実施例3~4及び比較例2において得られた増殖曲線を図3に示す。また、β‐ガラクトシダーゼ活性の評価結果(インキュベート時間:1時間)を表2に示す。さらに、比較例2の第3の工程の培養開始時(0時間培養後)の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を示す写真を図4Aに、実施例3~4及び比較例2の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を示す写真を図4Bに、実施例3~4及び比較例2の第3の工程の培養開始から6時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:1時間)を実施したときの外観を示す写真を図4Cに、それぞれ示す。 The growth curves obtained in Examples 3 to 4 and Comparative Example 2 are shown in FIG. Table 2 shows the evaluation results of β-galactosidase activity (incubation time: 1 hour). Further, FIG. 4A shows a photograph showing an external appearance when β-galactosidase activity evaluation (incubation time: 1 hour) is performed on the culture solution at the start of culture (after 0 hour culture) in the third step of Comparative Example 2. FIG. 4B is a photograph showing the external appearance when the β-galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 3 hours of culture from the start of the third step of Examples 3 to 4 and Comparative Example 2. In addition, photographs showing the appearance when β-galactosidase activity evaluation (incubation time: 1 hour) was performed on the culture solution after 6 hours of culture from the start of the culture in the third step of Examples 3 to 4 and Comparative Example 2. Each is shown in FIG. 4C.
 また、比較例2の第3の工程の培養開始時(0時間培養後)の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:3時間)を実施したときの外観を示す写真を図5Aに、実施例3~4及び比較例2の第3の工程の培養開始から3時間培養後の培養液についてβ‐ガラクトシダーゼ活性評価(インキュベート時間:3時間)を実施したときの外観を示す写真を図5Bに、それぞれ示す。 Moreover, the photograph which shows the external appearance when implementing beta-galactosidase activity evaluation (incubation time: 3 hours) about the culture solution at the time of the culture | cultivation start (after 0-hour culture | cultivation) of the 3rd process of the comparative example 2 to FIG. 5A, FIG. 5B is a photograph showing the external appearance when the β-galactosidase activity evaluation (incubation time: 3 hours) was performed on the culture solution after 3 hours of cultivation from the start of the third step in Examples 3 to 4 and Comparative Example 2. Respectively.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 以上の結果から明らかなように、本発明の製造方法(実施例1~4)においては、第3の工程において、低温菌及び中温菌(大腸菌)に由来する酵素(β‐ガラクトシダーゼ)をコードするDNA(lacZ)を導入した形質転換体の増殖が抑制され、かつ、前記酵素が十分に発現することが確認された。 As is clear from the above results, in the production method of the present invention (Examples 1 to 4), in the third step, an enzyme (β-galactosidase) derived from psychrophilic bacteria and mesophilic bacteria (E. coli) is encoded. It was confirmed that the growth of the transformant introduced with DNA (lacZ) was suppressed and the enzyme was sufficiently expressed.
 以上説明したように、本発明によれば、低温菌及び中温菌に由来する酵素をコードするDNAを導入した形質転換体の増殖段階と前記酵素の発現段階とを分けることができる低温菌及び中温菌由来酵素の製造方法を提供することが可能となる。 As described above, according to the present invention, a psychrophilic bacterium and a mesophilic temperature capable of separating the growth stage of a transformant introduced with DNA encoding an enzyme derived from psychrophilic bacteria and mesophilic bacteria and the expression stage of the enzyme. It is possible to provide a method for producing a bacterium-derived enzyme.
配列番号:1
<223> HM48プライマー
配列番号:2
<223> HM49プライマー
配列番号:4
<223> pNW33Nプラスミド
配列番号:5
<223> HM05bプライマー
配列番号:6
<223> HM06‐minusプライマー
配列番号:7
<223> HM51プライマー
配列番号:8
<223> HM52Hプライマー
配列番号:9
<223> pESG21Hプラスミド
配列番号:11
<223> HindIII-promoter-fwプライマー
配列番号:12
<223> promoter‐rvプライマー
配列番号:13
<223> promoter-bGalE-fwプライマー
配列番号:14
<223> HindIII-H6-bGalE-rvプライマー
配列番号:15
<223> HM58プライマー
配列番号:16
<223> HM60プライマー
SEQ ID NO: 1
<223> HM48 primer SEQ ID NO: 2
<223> HM49 primer SEQ ID NO: 4
<223> pNW33N plasmid SEQ ID NO: 5
<223> HM05b primer SEQ ID NO: 6
<223> HM06-minus primer SEQ ID NO: 7
<223> HM51 primer SEQ ID NO: 8
<223> HM52H primer SEQ ID NO: 9
<223> pESG21H plasmid SEQ ID NO: 11
<223> HindIII-promoter-fw primer SEQ ID NO: 12
<223> promoter-rv primer SEQ ID NO: 13
<223> promoter-bGalE-fw primer SEQ ID NO: 14
<223> HindIII-H6-bGalE-rv primer SEQ ID NO: 15
<223> HM58 primer SEQ ID NO: 16
<223> HM60 primer

Claims (5)

  1.  至適増殖温度が50℃以上である好熱菌に、至適増殖温度が50℃以下かつ前記好熱菌の至適増殖温度よりも10℃以上低い温度である低温菌及び中温菌からなる群から選択される少なくとも1種の微生物に由来する酵素をコードするDNAを導入して、形質転換体を得る第1の工程と、
     50℃以上の培養温度で前記形質転換体を培養して増殖させる第2の工程と、
     第2の工程の後、培養温度を50℃以下かつ第2の工程の培養温度よりも10℃以上低い温度に変えて前記酵素を発現させる第3の工程と、
    を含む低温菌及び中温菌由来酵素の製造方法。
    A group consisting of a thermophilic bacterium having an optimal growth temperature of 50 ° C. or higher, a thermophilic bacterium having an optimal growth temperature of 50 ° C. or lower and a temperature lower by 10 ° C. or more than the optimal growth temperature of the thermophilic bacterium A first step of obtaining a transformant by introducing DNA encoding an enzyme derived from at least one microorganism selected from:
    A second step of culturing and growing the transformant at a culture temperature of 50 ° C. or higher;
    After the second step, a third step of expressing the enzyme by changing the culture temperature to 50 ° C. or lower and a temperature lower by 10 ° C. or higher than the culture temperature of the second step;
    A method for producing a thermophilic bacterium and an enzyme derived from a mesophilic bacterium.
  2.  第2の工程の培養温度が55~87℃である請求項1に記載の低温菌及び中温菌由来酵素の製造方法。 The method for producing enzymes derived from psychrophilic bacteria and mesophilic bacteria according to claim 1, wherein the culture temperature in the second step is 55 to 87 ° C.
  3.  第3の工程の培養温度が25~45℃である請求項1又は2に記載の低温菌及び中温菌由来酵素の製造方法。 The method for producing enzymes derived from psychrophilic bacteria and mesophilic bacteria according to claim 1 or 2, wherein the culture temperature in the third step is 25 to 45 ° C.
  4.  前記形質転換体を培養する培養液のOD600が1以下であるときに第2の工程の培養温度から第3の工程の培養温度に変える請求項1~3のうちのいずれか一項に記載の低温菌及び中温菌由来酵素の製造方法。 The culture temperature of the second step is changed to the culture temperature of the third step when the OD 600 of the culture medium for culturing the transformant is 1 or less. Process for producing psychrophilic and mesophilic bacteria-derived enzymes.
  5.  請求項1~4のうちのいずれか一項に記載の低温菌及び中温菌由来酵素の製造方法で得られた酵素と前記酵素の基質とを接触させて反応せしめる、酵素反応方法。 An enzyme reaction method in which an enzyme obtained by the method for producing an enzyme derived from a psychrotrophic bacterium or a mesophilic bacterium according to any one of claims 1 to 4 is brought into contact with a substrate of the enzyme to react.
PCT/JP2017/010265 2016-03-29 2017-03-14 Method for producing enzyme derived from psychrophilic or mesophilic microorganism WO2017169751A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018508977A JPWO2017169751A1 (en) 2016-03-29 2017-03-14 Process for producing thermophilic bacteria and enzymes derived from mesophilic bacteria

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-065351 2016-03-29
JP2016065351 2016-03-29

Publications (1)

Publication Number Publication Date
WO2017169751A1 true WO2017169751A1 (en) 2017-10-05

Family

ID=59965237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/010265 WO2017169751A1 (en) 2016-03-29 2017-03-14 Method for producing enzyme derived from psychrophilic or mesophilic microorganism

Country Status (2)

Country Link
JP (1) JPWO2017169751A1 (en)
WO (1) WO2017169751A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146585A (en) * 1981-03-06 1982-09-10 Shionogi & Co Ltd Transforming method with insertion of plasmid
JPH06237774A (en) * 1992-12-24 1994-08-30 Nec Corp Plasmid
JP2005261360A (en) * 2004-03-19 2005-09-29 Osaka Gas Co Ltd Highly active promotor functioning in bacterium of genus thermus
JP2011160778A (en) * 2010-02-15 2011-08-25 Thermostable Enzyme Laboratory Co Ltd New immobilized thermostable enzyme
WO2015190457A1 (en) * 2014-06-09 2015-12-17 株式会社カネカ Method for producing recombinant proteins using recombinant brevibacillus

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146585A (en) * 1981-03-06 1982-09-10 Shionogi & Co Ltd Transforming method with insertion of plasmid
JPH06237774A (en) * 1992-12-24 1994-08-30 Nec Corp Plasmid
JP2005261360A (en) * 2004-03-19 2005-09-29 Osaka Gas Co Ltd Highly active promotor functioning in bacterium of genus thermus
JP2011160778A (en) * 2010-02-15 2011-08-25 Thermostable Enzyme Laboratory Co Ltd New immobilized thermostable enzyme
WO2015190457A1 (en) * 2014-06-09 2015-12-17 株式会社カネカ Method for producing recombinant proteins using recombinant brevibacillus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIAO H. ET AL.: "Isolation of a thermostable enzyme variant by cloning and selection in a thermophile", PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 576 - 580, XP000971054, ISSN: 0027-8424 *
SHINSUKE FUJIWARA ET AL.: "Konetsukin Kenkyu no Ima: Koon Tekio kara Teion Tekio e", BIOTECHNOLOGY, vol. 90, no. 11, 2012, pages 701 - 705, ISSN: 0919-3758 *
SUZUKI H. ET AL.: "Thermoadaptation-directed enzyme evolution in an error-prone thermophile derived from Geobacillus kaustophilus HTA426", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 81, no. 1, 2015, pages 149 - 158, XP055427778, ISSN: 0099-2240 *

Also Published As

Publication number Publication date
JPWO2017169751A1 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
TWI682998B (en) A composition for producing tagatose and methods for producing tagatose using the same
EP3315610B1 (en) Process for the production of fucosylated oligosaccharides
Jiang et al. Engineering the bacterial shapes for enhanced inclusion bodies accumulation
Potter et al. Influence of homologous phasins (PhaP) on PHA accumulation and regulation of their expression by the transcriptional repressor PhaR in Ralstonia eutropha H16
JP6730199B2 (en) Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
McCool et al. Polyhydroxyalkanoate inclusion body-associated proteins and coding region in Bacillus megaterium
CN110869508A (en) Fucosyltransferases and their use in the production of fucosylated oligosaccharides
Peters et al. Deletion of pyruvate decarboxylase by a new method for efficient markerless gene deletions in Gluconobacter oxydans
Kranz et al. Polyhydroxyalkanoate production in Rhodobacter capsulatus: genes, mutants, expression, and physiology
He et al. Construction of a food grade recombinant Bacillus subtilis based on replicative plasmids with an auxotrophic marker for biotransformation of D-fructose to D-allulose
Peng et al. An upstream activation element exerting differential transcriptional activation on an archaeal promoter
UA80976C2 (en) Processes and materials for production of d-lactic acid in yeast
Meng et al. Production of poly (3-hydroxypropionate) and poly (3-hydroxybutyrate-co-3-hydroxypropionate) from glucose by engineering Escherichia coli
Sato et al. Construction of a stable plasmid vector for industrial production of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) by a recombinant Cupriavidus necator H16 strain
EP2540835B1 (en) PROCESS FOR PRODUCTION OF POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE) USING A GENETICALLY MODIFIED CUPRIAVIDUS NECATOR HAVING AN ENOYL-CoA HYDRATASE GENE INTRODUCED THEREIN
JPH06510425A (en) Method for producing poly-β-hydroxyalkanoate copolymer
Jakob et al. Comparison of novel GH 68 levansucrases of levan-overproducing Gluconobacter species
Kniewel et al. Biogenesis of medium-chain-length polyhydroxyalkanoates
Riaz et al. Metabolic engineered biocatalyst: a solution for PLA based problems
Horng et al. Inactivation of dhaD and dhaK abolishes by-product accumulation during 1, 3-propanediol production in Klebsiella pneumoniae
Nahálka Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to α-d-glucose-1-phosphate
CN117904018A (en) Alcohol dehydrogenase variants
TW201842188A (en) A composition for producing tagatose and methods for producing tagatose using the same
WO2016021604A1 (en) Method for producing polyhydroxyalkanoate copolymer from saccharide raw material
JP2009225662A (en) Method for providing c. necator with glucose assimilating property and method for producing pha using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2018508977

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17774295

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17774295

Country of ref document: EP

Kind code of ref document: A1